Angela Vincent

Q: What Schools Are Affiliated With Angela Vincent

Angela Vincent is affiliated with the following schools: University of Bergen, University College London, University of Oxford, Nagasaki University, Institute of Science Tokyo, King's College London

Angela Vincent's AcademicInfluence.com Rankings

Angela Vincent

Medical

#571

World Rank

#770

Historical Rank

Neurosurgery

#16

World Rank

#20

Historical Rank

medical Degrees

Angela Vincent

Philosophy

#2887

World Rank

#4791

Historical Rank

Logic

#829

World Rank

#1378

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Angela Vincent's Degrees

Bachelors Medicine University of Oxford

Why Is Angela Vincent Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Angela Vincent is Emeritus professor at the University of Oxford and a Fellow of Somerville College, Oxford. Career and research Angela Vincent was born in 1942, the third child of Carmen and Joseph Molony . After St Mary's Convent, Ascot, she studied medicine at King's College London and Westminster Hospital School of Medicine . After one year as a junior doctor at St Steven's and St Charles' hospitals in London , she obtained an MSc in biochemistry from University College London. In 1967 she married Philip Morse Vincent and they have four children.

(See a Problem?)

Angela Vincent's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A clinical approach to diagnosis of autoimmune encephalitis (2016) (2278)
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia (2010) (1134)
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies (2001) (1075)
Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. (2004) (1005)
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes (2010) (921)
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. (2010) (908)
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings (2020) (787)
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis (2011) (757)
Autoantibodies associated with diseases of the CNS: new developments and future challenges (2011) (516)
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. (2012) (504)
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. (2010) (476)
Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. (1980) (471)
Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. (2014) (470)
Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis (2010) (434)
IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis† (2008) (432)
Clinical presentation and prognosis in MOG-antibody disease: a UK study (2017) (426)
Potassium channel antibodies in two patients with reversible limbic encephalitis (2001) (425)
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype (2012) (405)
Morvan syndrome: Clinical and serological observations in 29 cases (2012) (404)
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica (2008) (399)
Acquired neuromyotonia: Evidence for autoantibodies directed against K+ channels of peripheral nerves (1995) (395)
Unravelling the pathogenesis of myasthenia gravis (2002) (384)
Phenotypic variants of autoimmune peripheral nerve hyperexcitability. (2002) (381)
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system (2007) (380)
Clinical aspects of MuSK antibody positive seronegative MG (2003) (380)
Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes (2014) (375)
Detection and characterization of MuSK antibodies in seronegative myasthenia gravis (2004) (372)
Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. (2001) (367)
Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. (1985) (366)
GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction (2013) (365)
AUTOIMMUNE AETIOLOGY FOR MYASTHENIC (EATON-LAMBERT) SYNDROME (1981) (348)
Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. (2013) (347)
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. (2012) (339)
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. (2001) (332)
Randomized Trial of Thymectomy in Myasthenia Gravis. (2016) (326)
Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. (2010) (323)
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia (1997) (320)
Serologic diagnosis of NMO (2012) (310)
Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica (2008) (308)
Disease-relevant autoantibodies in first episode schizophrenia (2010) (303)
Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. (2008) (295)
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease (2015) (294)
Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances (2014) (292)
PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY (2008) (289)
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. (1983) (283)
Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition (2012) (279)
Function of circulating antibody to acetylcholine receptor in myasthenia gravis (1978) (270)
An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. (1995) (247)
Dok-7 Mutations Underlie a Neuromuscular Junction Synaptopathy (2006) (246)
Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line (1985) (240)
Fewer thymic changes in MuSK antibody‐positive than in MuSK antibody‐negative MG (2005) (238)
MYASTHENIA GRAVIS WITHOUT ACETYLCHOLINE-RECEPTOR ANTIBODY: A DISTINCT DISEASE ENTITY (1986) (231)
Serum antibodies in epilepsy and seizure-associated disorders (2005) (231)
Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome (1996) (229)
Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens (2012) (226)
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer (2002) (223)
Postsynaptic Abnormalities at the Neuromuscular Junctions of Utrophin-deficient Mice (1997) (223)
Acetylcholine receptors in human thymic myoid cells in situ: An immunohistological study (1987) (223)
The importance of early immunotherapy in patients with faciobrachial dystonic seizures (2017) (222)
Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome) (1991) (220)
N‐methyl‐D‐aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica (2009) (213)
Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy (2007) (213)
Antibody to Aquaporin 4 in the Diagnosis of Neuromyelitis Optica (2007) (211)
Evidence of underdiagnosis of myasthenia gravis in older people (2003) (206)
Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy (2013) (205)
Maternal neuronal antibodies associated with autism and a language disorder (2003) (200)
Immunology of acetylcholine receptors in relation to myasthenia gravis. (1980) (198)
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets (2003) (197)
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica (2016) (194)
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children (2015) (192)
Rapid eye movement sleep behavior disorder and potassium channel antibody–associated limbic encephalitis (2006) (190)
N‐methyl‐D‐aspartate receptor antibodies in post–herpes simplex virus encephalitis neurological relapse (2014) (190)
An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus (2007) (189)
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS (2015) (188)
Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. (2019) (187)
Autoimmune encephalopathies. (2015) (186)
Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort (2019) (185)
Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis (2017) (183)
LONG-TERM EFFECTS OF REPEATED PLASMA EXCHANGE IN MYASTHENIA GRAVIS (1979) (183)
Acetylcholine receptor antibody synthesis by thymic lymphocytes (1981) (178)
NMO-IgG in the diagnosis of neuromyelitis optica (2007) (178)
MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. (2006) (171)
Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases (2008) (168)
Voltage‐gated potassium channel antibodies in limbic encephalitis (2003) (165)
Acetylcholine receptors loss and postsynaptic damage in MuSK antibody–positive myasthenia gravis (2005) (163)
Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome (2011) (163)
Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder (1989) (162)
Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release (1994) (162)
Acetylcholine receptor antibody characteristics in myasthenia gravis. I. Patients with generalized myasthenia or disease restricted to ocular muscles. (1982) (162)
Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy. (2009) (161)
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis (2010) (158)
Management of suspected viral encephalitis in children - Association of British Neurologists and British Paediatric Allergy, Immunology and Infection Group national guidelines. (2012) (156)
Neuroinflammation: Ways in Which the Immune System Affects the Brain (2015) (156)
Mature, long‐lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis (2001) (154)
Neutrophil protease inhibition reduces neuromyelitis optica–immunoglobulin G–induced damage in mouse brain (2012) (153)
Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis (2007) (150)
Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. (1996) (150)
IN-VITRO SYNTHESIS OF ANTI-ACETYLCHOLINE-RECEPTOR ANTIBODY BY THYMIC LYMPHOCYTES IN MYASTHENIA GRAVIS (1978) (149)
Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. (1997) (149)
Cell-surface central nervous system autoantibodies: Clinical relevance and emerging paradigms (2014) (149)
Limbic encephalitis in children and adolescents (2010) (148)
Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. (2006) (148)
Anti-acetylcholine receptor antibodies. (1980) (146)
Arthrogryposis multiplex congenita with maternal autoantibodies specific for a fetal antigen (1995) (144)
Clinical and serological study of myasthenia gravis in HuBei Province, China (2006) (143)
CLINICAL SPECTRUM OF VOLTAGE-GATED POTASSIUM CHANNEL AUTOIMMUNITY (2009) (143)
Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis (2005) (143)
IMMUNOTHERAPY-RESPONSIVE SEIZURE-LIKE EPISODES WITH POTASSIUM CHANNEL ANTIBODIES (2008) (140)
Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS. (2011) (136)
Diagnostic algorithm for relapsing acquired demyelinating syndromes in children (2017) (136)
Miller Fisher anti‐GQ1b antibodies: α‐Latrotoxin–like effects on motor end plates (1999) (135)
MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters (2013) (135)
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. (2008) (134)
Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage‐gated sodium channels (2005) (133)
Strong association of MuSK antibody–positive myasthenia gravis and HLA-DR14-DQ5 (2006) (132)
Ion channels in genetic and acquired forms of epilepsy (2013) (132)
Antiglycine-receptor encephalomyelitis with rigidity (2010) (132)
Progressive encephalomyelitis with rigidity and myoclonus (2011) (128)
The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. (2010) (128)
Antibodies to voltage-gated potassium and calcium channels in epilepsy (2006) (128)
Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study. (2017) (127)
Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms (2016) (127)
Morvan’s syndrome associated with voltage-gated K channel antibodies (2000) (127)
Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre (2013) (126)
Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity (2014) (125)
Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1 (2008) (124)
Clinical comparison of muscle‐specific tyrosine kinase (MuSK) antibody‐positive and ‐negative myasthenic patients (2004) (122)
IL‐12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody‐ mediated disease (1998) (122)
Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis (2004) (121)
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease (2016) (120)
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain (2014) (119)
Development of innervation of skeletal muscle fibers in man: Relation to acetylcholine receptors (1993) (119)
Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology (2017) (119)
Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects (2012) (117)
Autoimmune Channelopathies and Related Neurological Disorders (2006) (117)
Myasthenia gravis and neuromyelitis optica spectrum disorder (2012) (117)
Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis (1996) (117)
Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis. (2012) (116)
Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. (2000) (116)
Congenital myasthenia: End‐plate acetylcholine receptors and electrophysiology in five cases (1981) (115)
Autoimmune Disorders of Neuronal Potassium Channels (2003) (114)
Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis. (1978) (112)
N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children (2015) (111)
Antibodies in Myasthenia Gravis and Related Disorders (2003) (110)
Myasthenia Gravis Seronegative for Acetylcholine Receptor Antibodies (2008) (109)
The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins (2010) (108)
Human limbic encephalitis serum enhances hippocampal mossy fiber‐CA3 pyramidal cell synaptic transmission (2011) (108)
Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies (2017) (108)
NMDA Receptor Antibody Encephalitis (2011) (108)
Infectious and Autoantibody-Associated Encephalitis: Clinical Features and Long-term Outcome (2015) (108)
Multifocal motor neuropathy human sera block distal motor nerve conduction in mice (1995) (108)
The spectrum of mutations causing end‐plate acetylcholinesterase deficiency (2000) (108)
Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status. (2007) (108)
Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability (2018) (107)
Antibodies to GABAA receptor α1 and γ2 subunits (2015) (107)
The human muscle nicotinic acetylcholine receptor alpha‐subunit exist as two isoforms: a novel exon. (1990) (105)
Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia (2012) (103)
Antibody-mediated encephalitis: a treatable cause of schizophrenia (2012) (103)
Thymus changes in anti-MuSK-positive and -negative myasthenia gravis (2005) (102)
VGKC antibodies in pediatric encephalitis presenting with status epilepticus (2011) (102)
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial (2019) (102)
Myasthenia gravis (1987) (101)
Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis (1998) (101)
Myasthenia gravis: a clinical-immunological update (2015) (100)
Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence? (2001) (99)
Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis (1983) (99)
Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome (2015) (98)
Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes (2014) (98)
A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. (1996) (98)
Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis. (2015) (97)
Passive transfer of seronegative myasthenia gravis to mice (1994) (96)
Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis (1997) (94)
NMDA receptor antibodies associated with distinct white matter syndromes (2014) (93)
Incidence and prevalence of NMOSD in Australia and New Zealand (2017) (92)
Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies (1999) (92)
Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features (2014) (91)
Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. (2013) (91)
Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells. (1991) (91)
Antibody Heterogeneity and Specificity in Myasthenia Gravis a (1987) (90)
Myasthenia gravis (2001) (90)
Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. (2000) (90)
Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. (1999) (88)
Autoimmune epilepsy in children: Case series and proposed guidelines for identification (2013) (88)
Rapsyn mutations in hereditary myasthenia (2003) (87)
Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer. (2004) (87)
The search for new antigenic targets in myasthenia gravis (2012) (86)
New autoantibody mediated disorders of the central nervous system. (2003) (86)
Spontaneous neutralising antibodies to interferon-a and interleukin-12 in thymoma-associated autoimmune disease (1997) (85)
The agrin/muscle‐specific kinase pathway: New targets for autoimmune and genetic disorders at the neuromuscular junction (2002) (85)
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies (2013) (85)
Neuromyelitis Optica IgG Causes Placental Inflammation and Fetal Death (2013) (85)
Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. (1994) (84)
Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica (2008) (84)
Paraneoplastic neurologic disorders in small cell lung carcinoma (2015) (84)
Anti-N-methyl-D-aspartate receptor antibodies: A potentially treatable cause of encephalitis in the intensive care unit (2010) (83)
CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis (2008) (82)
Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes (2002) (81)
Pregnancy outcomes in aquaporin-4–positive neuromyelitis optica spectrum disorder (2016) (81)
Mutation of the acetylcholine receptor ε‐subunit promoter in congenital myasthenic syndrome (1999) (79)
IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients. (2017) (79)
Neuromuscular transmission after immunization against acetylcholine receptors (1975) (78)
Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies (2015) (78)
Systemic and neurologic autoimmune disorders associated with seizures or epilepsy (2011) (78)
Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice. (1999) (78)
Molecular targets for autoimmune and genetic disorders of neuromuscular transmission. (2000) (77)
A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes. (1998) (77)
Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model. (2015) (77)
Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults (2008) (76)
Seronegative myasthenia gravis: A plasma factor inhibiting agonist‐induced acetylcholine receptor function copurifies with IgM (1991) (76)
Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia (2009) (76)
Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort (2013) (74)
The slow channel syndrome. Two new cases. (1987) (74)
Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. (2005) (73)
Investigation of neuronal autoantibodies in two different focal epilepsy syndromes (2014) (72)
Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis (2017) (72)
Autoimmune synaptopathies (2016) (71)
Caspr2 Antibodies in Patients with Thymomas (2010) (71)
Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptors (2014) (70)
Sjögren’s syndrome myelopathy: spinal cord involvement in Sjögren’s syndrome might be a manifestation of neuromyelitis optica (2009) (70)
Autoimmune mediated neuromuscular junction defects. (2010) (70)
IgG from “seronegative” myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor (2000) (70)
Febrile Infection-Related Epilepsy Syndrome without Detectable Autoantibodies and Response to Immunotherapy: A Case Series and Discussion of Epileptogenesis in FIRES (2012) (69)
Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients (2011) (69)
Diagnostic use of autoantibodies in myasthenia gravis (2010) (69)
Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. (1995) (69)
Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica (2009) (69)
Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor. (2003) (69)
α7-Acetylcholine receptor antibodies in two patients with Rasmussen encephalitis (2005) (68)
Autoimmunizing Mechanisms in Thymoma and Thymus * (2008) (68)
A transfected human muscle cell line expressing the adult subtype of the human muscle acetylcholine receptor for diagnostic assays in myasthenia gravis (1996) (67)
Scenarios for Autoimmunization of T and B Cells in Myasthenia Gravis (2003) (67)
AChR phosphorylation and indirect inhibition of AChR function in seronegative MG (2002) (67)
Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor Function a (1993) (66)
Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese (2004) (66)
Immunological Heterogeneity and Cellular Mechanisms in Myasthenia Gravis a (1987) (66)
Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: The role of electromyogram‐guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test (2006) (65)
Faculty Opinions recommendation of Pten regulates neuronal arborization and social interaction in mice. (2006) (65)
How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia (2014) (65)
Autoimmune encephalitis -- new awareness, challenging questions. (2011) (63)
Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis (2005) (63)
Lambert‐Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end‐plate (1987) (63)
Autoimmune disorders of the neuromuscular junction. (2009) (63)
Intravenous immunoglobulin response and evidence for pathogenic antibodies in a case of complex regional pain syndrome 1 (2005) (62)
Persistent anterograde amnesia following limbic encephalitis associated with antibodies to the voltage-gated potassium channel complex (2014) (62)
Cell- and Single Molecule-Based Methods to Detect Anti-N-Methyl-D-Aspartate Receptor Autoantibodies in Patients With First-Episode Psychosis From the OPTiMiSE Project (2017) (62)
Autoantibodies to neuronal antigens in children with new‐onset seizures classified according to the revised ILAE organization of seizures and epilepsies (2013) (62)
Genes at the junction – candidates for congenital myasthenic syndromes (1997) (62)
Immunotherapy for patients with acute psychosis and serum N-Methyl d-Aspartate receptor (NMDAR) antibodies: A description of a treated case series (2014) (62)
LIMBIC ENCEPHALITIS ASSOCIATED WITH ANTIBODIES TO THE NMDA RECEPTOR IN HODGKIN LYMPHOMA (2009) (62)
Primary structure of the human muscle acetylcholine receptor (1993) (62)
Clinical relevance of voltage-gated potassium channel–complex antibodies in children (2015) (61)
MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo (2005) (61)
Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica (2009) (60)
FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti–NDMA-R antibodies encephalitis (2010) (59)
Ocular Myasthenia Gravis: Controversies and Updates (2013) (59)
Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies (2006) (59)
Monoclonal antibodies that distinguish between normal and denervated human acetylcholine re receptor (1986) (59)
Do Neuronal Autoantibodies Cause Psychosis? A Neuroimmunological Perspective (2014) (59)
Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies. (2013) (59)
A TRANSIENT NEONATAL MYASTHENIC SYNDROME WITH ANTI-MUSK ANTIBODIES (2008) (58)
Suspected limbic encephalitis and seizure in cats associated with voltage-gated potassium channel (VGKC) complex antibody. (2013) (58)
Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library. (1997) (58)
FDG‐PET and MRI in potassium channel antibody‐associated non‐paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology (2005) (57)
Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays (2012) (56)
Elevated VGKC‐complex antibodies in a boy with fever‐induced refractory epileptic encephalopathy in school‐age children (FIRES) (2011) (55)
ANTI-ACETYLCHOLINE RECEPTOR ANTIBODIES IN D-PENICILLAMINE-ASSOCIATED MYASTHENIA GRAVIS (1978) (55)
Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis. (2011) (55)
Human African Trypanosomiasis Presenting at Least 29 Years after Infection—What Can This Teach Us about the Pathogenesis and Control of This Neglected Tropical Disease? (2014) (54)
Progressive encephalomyelitis with rigidity and myoclonus: Resolution after thymectomy (2011) (54)
Antibodies to Acetylcholine Receptor in Parous Women with Myasthenia: Evidence for Immunization by Fetal Antigen (2002) (54)
Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome. (2013) (54)
The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis (2020) (54)
Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells (1995) (54)
Diseases of the neuromuscular junction. (2002) (53)
Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson’s disease (2008) (53)
Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases (2015) (53)
Autoantibodies to ion channels at the neuromuscular junction. (2003) (53)
Immune responses to Campylobacter and serum autoantibodies in patients with complex regional pain syndrome (2005) (53)
Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations (2012) (52)
Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study. (2004) (52)
Postencephalitic epilepsy and drug‐resistant epilepsy after infectious and antibody‐associated encephalitis in childhood: Clinical and etiologic risk factors (2016) (52)
Immunological evidence for the co-existence of the Lambert-Eaton myasthenic syndrome and myasthenia gravis in two patients. (1991) (52)
Single‐fiber electromyography in limb and facial muscles in muscle‐specific kinase antibody and acetylcholine receptor antibody myasthenia gravis (2006) (52)
Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis (2012) (52)
Immunology of disorders of neuromuscular transmission (2006) (52)
Complement activation in patients with neuromyelitis optica (2014) (52)
Prospective Study into the Incidence of Lambert Eaton Myasthenic Syndrome in Small Cell Lung Cancer (2010) (52)
Early‐onset myasthenia gravis: A recurring T‐cell epitope in the adult‐specific acetylcholine receptor ε subunit presented by the susceptibility allele HLA‐DR52a (1999) (51)
Stable functional expression of the adult subtype of human muscle acetylcholine receptor following transfection of the human rhabdomyosarcoma cell line TE671 with cDNA encoding the ε subunit (1996) (51)
Hypothermia in VGKC antibody-associated limbic encephalitis (2008) (51)
The role of T-cells in the initiation of autoantibody responses in thymoma patients. (1999) (51)
Expression of foetal type acetylcholine receptor is restricted to type 1 muscle fibres in human neuromuscular disorders. (2002) (50)
Lambert‐eaton myasthenic syndrome: Immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity (1989) (50)
Peripheral nerve hyperexcitability (2011) (50)
Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line (2001) (49)
Pathogenic autoantibodies to neuronal proteins in neurological disorders (1999) (49)
Causes, presentation and outcome of lesional adult onset mediotemporal lobe epilepsy (2009) (49)
A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro (1990) (49)
A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment. (2013) (49)
Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy (1998) (48)
Pathogenic Autoantibodies in the Lambert‐Eaton Myasthenic Syndrome (2003) (47)
End-plate gamma- and epsilon-subunit mRNA levels in AChR deficiency syndrome due to epsilon-subunit null mutations. (2001) (47)
Lambert-Eaton myasthenic syndrome: electrophysiological evidence for a humoral factor. (1982) (46)
IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG (2017) (46)
Pathogenic autoimmunity to affinity‐purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice (1993) (46)
Diverse molecular mechanisms involved in AChR deficiency due to rapsyn mutations. (2006) (46)
The role of muscle‐specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis (2014) (46)
NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease (2012) (46)
Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671 cell line (1988) (46)
Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels (2010) (46)
Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response (2001) (45)
Functional and non‐functional isoforms of the human muscle acetylcholine receptor. (1995) (45)
Neuroimaging in encephalitis: analysis of imaging findings and interobserver agreement (2016) (45)
Novel functional ε‐subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome (1999) (44)
Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4 (2008) (44)
Immune‐mediated steroid‐responsive epileptic spasms and epileptic encephalopathy associated with VGKC‐complex antibodies (2011) (43)
Anti‐Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus (2001) (43)
Autoimmunity to ion-channels and other proteins in paraneoplastic disorders. (1996) (43)
Acetylcholine in intercostal muscle from myasthenia gravis patients and in rat diaphragm after blockade of acetylcholine receptors. (1979) (43)
Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome. (1997) (43)
A radioimmunoprecipitation assay for antibodies to botulinum A (1998) (42)
Isolated new onset ‘atypical’ optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up (2016) (42)
Aetiological factors in development of myasthenia gravis. (1994) (42)
Acetylcholine in human muscle (1976) (41)
Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis. (2007) (41)
Serological and experimental studies in different forms of myasthenia gravis (2018) (41)
AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD (2019) (41)
The reliability of production strategy scores for the Ruff Figural Fluency Test. (2003) (41)
Mutations in congenital myasthenic syndromes reveal an epsilon subunit C-terminal cysteine, C470, crucial for maturation and surface expression of adult AChR. (2002) (41)
Rhabdomyosarcoma lysis by T cells expressing a human autoantibody-based chimeric receptor targeting the fetal acetylcholine receptor. (2006) (41)
Epitopes on human acetylcholine receptor defined by monoclonal antibodies and myasthenia gravis sera. (1988) (41)
Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease (2014) (41)
Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression. (2007) (41)
Autoantibodies in patients with gut motility disorders and enteric neuropathy (2007) (41)
Myasthenia gravis: diagnostic and management dilemmas (2001) (41)
The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates. (2009) (41)
Myasthenia gravis (1986) (40)
Pilomotor seizures and status in non-paraneoplastic limbic encephalitis. (2005) (40)
Response to human acetylcholine receptor alpha 138-199: determinant spreading initiates autoimmunity to self-antigen in rabbits. (1994) (40)
Antiglycine receptor antibody related disease: a case series and literature review (2018) (40)
The fetal form of the acetylcholine receptor distinguishes rhabdomyosarcomas from other childhood tumors. (1998) (40)
Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies (2007) (40)
Persistent microglial activation and synaptic loss with behavioral abnormalities in mouse offspring exposed to CASPR2-antibodies in utero (2017) (40)
Thymoma-Associated Neuromyotonia with Antibodies against Voltage-Gated Potassium Channels Presenting as Chronic Intestinal Pseudo-Obstruction (2005) (40)
The passive transfer of immunoglobulin G serum antibodies from patients with longstanding Complex Regional Pain Syndrome. (2011) (39)
Collagen Q – A potential target for autoantibodies in myasthenia gravis (2015) (39)
Prevention of autoimmune attack by targeting specific T‐cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis (1999) (39)
Transmitter release induced by a ‘factor’ in rabbit serum (1974) (39)
IgG and complement deposition and neuronal loss in cats and humans with epilepsy and voltage-gated potassium channel complex antibodies. (2014) (39)
Encephalitis lethargica: part of a spectrum of post-streptococcal autoimmune diseases? (2004) (39)
Induction of primary immune responses by allogeneic human myoblasts: dissection of the cell types required for proliferation, IFNγ secretion and cytotoxicity (1998) (39)
CALCIUM CHANNEL AUTOANTIBODIES IN LAMBERT-EATON MYASTHENIC SYNDROME (1989) (38)
Paraneoplastic limbic encephalitis associated with potassium channel antibodies: value of anti-glial nuclear antibodies in identifying the tumour (2007) (38)
Antibodies identified by cell‐based assays in myasthenia gravis and associated diseases (2012) (38)
T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement (2011) (38)
CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) (2013) (38)
Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures (2007) (38)
Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. (2016) (38)
Non-radioactive serological diagnosis of myasthenia gravis and clinical features of patients from Tianjin, China (2011) (38)
Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset. (1982) (38)
An international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin: the concept of autoimmune psychosis (2019) (37)
CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism (2017) (37)
Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients (2019) (36)
Passive transfer of myasthenia gravis by immunoglobulins: lack of correlation between AChR with antibody bound, acetylcholine receptor loss and transmission defect (1988) (36)
Autoimmune Channelopathies: Well-Established and Emerging Immunotherapy-Responsive Diseases of the Peripheral and Central Nervous Systems (2010) (36)
Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings (2016) (36)
Utrophin abundance is reduced at neuromuscular junctions of patients with both inherited and acquired acetylcholine receptor deficiencies. (1997) (36)
Stiff, twitchy or wobbly: are GAD antibodies pathogenic? (2008) (36)
Glycine receptor autoantibodies disrupt inhibitory neurotransmission (2019) (36)
Autoantibodies in sporadic Creutzfeldt-Jakob disease. (2013) (36)
Anti‐acetylcholine receptor antibody specificities in serum and in thymic cell culture supernatants from myasthenia gravis patients (1988) (36)
Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis (1996) (36)
Pharmacokinetics and bronchial diffusion of single daily dose amikacin in cystic fibrosis patients. (1997) (36)
Physicochemical and immunological studies of the N-terminal domain of the Torpedo acetylcholine receptor alpha-subunit expressed in Escherichia coli. (1999) (35)
Eaton‐Lambert syndrome (1982) (35)
Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia (2018) (35)
An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre (2015) (35)
Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica (2013) (35)
ANTI‐ACETYLCHOLINE RECEPTOR ANTIBODY SYNTHESIS BY CULTURED LYMPHOCYTES IN MY ASTHENIA GRAVIS: THYMIC AND PERIPHERAL BLOOD CELL INTERACTIONS * (1981) (35)
Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder (2014) (35)
Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults (2011) (35)
Monoclonal antibodies to Torpedo acetylcholine receptor. Characterisation of antigenic determinants within the cholinergic binding site. (1985) (35)
FETAL ACETYLCHOLINE RECEPTOR INACTIVATION SYNDROME AND MATERNAL MYASTHENIA GRAVIS (2008) (35)
Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up (2019) (34)
Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy. (1981) (34)
N‐methyl‐d‐aspartate (NMDA) receptor antibodies encephalitis mimicking an autistic regression (2016) (34)
Tonic seizures: A diagnostic clue of anti-LGI1 encephalitis? (2011) (34)
alpha-Bungarotoxin and anti-acetylcholine receptor antibody binding to the human acetylcholine receptor. (1979) (34)
MuSK‐positive myasthenia gravis is rare in the Polish population (2008) (33)
Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions (2014) (33)
NMDA-receptor antibodies alter cortical microcircuit dynamics (2017) (33)
Antibodies Against Hypocretin Receptor 2 Are Rare in Narcolepsy (2017) (33)
Congenital Myasthenic Syndromes and the Formation of the Neuromuscular Junction (2008) (33)
Compromised fidelity of B‐cell tolerance checkpoints in AChR and MuSK myasthenia gravis (2016) (33)
Glycine receptor antibody mediated Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM): a rare but treatable neurological syndrome (2013) (33)
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease (2017) (33)
MuSK antibody-positive, seronegative myasthenia gravis in Korea (2006) (33)
High sensitivity and specificity in proposed clinical diagnostic criteria for anti‐N‐methyl‐D‐aspartate receptor encephalitis (2017) (33)
Low Levels of Vitamin D in Neuromyelitis Optica Spectrum Disorder: Association with Disease Disability (2014) (32)
Antibodies Affecting Ion Channel Function in Acquired Neuromyotonia, in Seropositive and Seronegative Myasthenia Gravis, and in Antibody‐mediated Arthrogryposis Multiplex Congenita (1998) (32)
The Role of Autoantibodies in Lambert‐Eaton Myasthenic Syndromea a (1998) (32)
A case of glycine-receptor antibody-associated encephalomyelitis with rigidity and myoclonus (PERM): clinical course, treatment and CSF findings (2011) (32)
Acquired slow–channel syndrome: A form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel (1998) (32)
Incidence of seropositive myasthenia gravis in Cape Town and South Africa. (2007) (32)
Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient (1993) (32)
Approaches for Studying the Pathogenic T Cells in Autoimmune Patients a (1993) (32)
Passive Transfer of Lambert‐Eaton Myasthenic Syndrome in Mice: Decreased Rates of Resting and Evoked Release of Acetylcholine from Skeletal Muscle (1984) (32)
A comparison of MyoD1 and fetal acetylcholine receptor expression in childhood tumors and normal tissues: implications for the molecular diagnosis of minimal disease in rhabdomyosarcomas. (1999) (32)
Autoantibody screening in subacute cerebellar ataxia (2000) (32)
Neuronal antibodies in pediatric epilepsy: Clinical features and long‐term outcomes of a historical cohort not treated with immunotherapy (2016) (31)
Antibodies to Neuronal Targets in Neurological and Psychiatric Diseases (2003) (31)
Antibodies to GABAA receptor &agr;1 and &ggr;2 subunits: Clinical and serologic characterization (2015) (31)
Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies (2016) (31)
Antibodies to 125I-glutamic acid decarboxylase in patients with stiff man syndrome. (1997) (31)
Fetal acetylcholine receptor inactivation syndrome (2014) (31)
IMMUNOTHERAPY-REVERSED COMPULSIVE, MONOAMINERGIC, CIRCADIAN RHYTHM DISORDER IN MORVAN SYNDROME (2008) (31)
Choline Acetyltransferase in Skeletal Muscle from Patients with Myasthenia Gravis (1981) (31)
Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations. (2002) (31)
ABSENCE OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODIES IN CONGENITAL MYASTHENIA GRAVIS (1979) (31)
Two isoforms of the muscle acetylcholine receptor α‐subunit are translated in the human cell line TE671 (1991) (31)
A mouse model of AChR deficiency syndrome with a phenotype reflecting the human condition. (2004) (31)
Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels. (1985) (31)
Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis (2016) (30)
Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. II. Receptor synthesis. (1983) (30)
N‐methyl‐D‐aspartate receptor antibody‐associated movement disorder without encephalopathy (2014) (30)
Immune-mediated rippling muscle disease with myasthenia gravis: A report of seven patients with long-term follow-up in two (2009) (30)
Characteristics Of acetylcholine‐receptor‐antibody–negative myasthenia gravis in a South African cohort (2016) (30)
Immunization against GAD Induces Antibody Binding to GAD-Independent Antigens and Brainstem GABAergic Neuronal Loss (2013) (30)
Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia (2010) (30)
The Structure, Function, and Physiology of the Fetal and Adult Acetylcholine Receptor in Muscle (2020) (29)
Redefining progressive encephalomyelitis with rigidity and myoclonus after the discovery of antibodies to glycine receptors (2017) (29)
Seronegative myasthenia gravis (1991) (29)
Transplacental transfer of NMDA receptor antibodies in an infant with cortical dysplasia (2014) (29)
Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome (2004) (29)
Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. I. Receptor degradation. (1983) (29)
Low‐voltage‐activated A‐current controls the firing dynamics of mouse hypothalamic orexin neurons (2004) (29)
Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration (2001) (28)
Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis (2014) (28)
Morvan's syndrome associated with antibodies to multiple components of the voltage-gated potassium channel complex (2012) (28)
The expanding spectrum of clinically-distinctive, immunotherapy-responsive autoimmune encephalopathies. (2012) (28)
Developments in autoimmune channelopathies. (2013) (28)
Monoclonal antibodies raised against human acetylcholine receptor bind to all five subunits of the fetal isoform (1999) (28)
A Role for Autoantibodies in Some Cases of Acquired Non-Paraneoplastic Gut Dysmotility (2002) (28)
Acetycholine receptor antibody characteristics in myasthenia gravis Fractionation of α-Bungarotoxin binding site antibodies and their relationship to IgG subclass (1983) (28)
Plasma cell depletion with bortezomib in the treatment of refractory N‐methyl‐d‐aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment (2018) (27)
Immunological and pharmacological heterogeneity of α-bungarotoxin binding sites extracted from TE671 cells (1988) (27)
Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome (2018) (27)
Behaviour and neuropathology in mice injected with human contactin-associated protein 2 antibodies. (2019) (27)
Neuromuscular transmission : basic and applied aspects (1992) (26)
Clinical and Experimental Observations in Patients with Congenital Myasthenic Syndromes a (1993) (26)
Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia (2005) (26)
Neuromuscular junction disorders. (2016) (26)
Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation (2005) (26)
Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes (2018) (26)
Pathogenic potential of antibodies to the GABAB receptor (2017) (26)
A Human Recombinant Autoantibody-Based Immunotoxin Specific for the Fetal Acetylcholine Receptor Inhibits Rhabdomyosarcoma Growth In Vitro and in a Murine Transplantation Model (2010) (26)
Sub-acute presentation of Morvan’s syndrome after thymectomy (2004) (26)
Immunoglobulin g for the treatment of chronic pain: report of an expert workshop. (2014) (26)
Fetal arthrogryposis and maternal serum antibodies (2006) (26)
Neuromyelitis optica in a child with Aicardi-GoutiÈres syndrome (2015) (26)
Maternal antibody-mediated dyslexia? Evidence for a pathogenic serum factor in a mother of two dyslexic children shown by transfer to mice using behavioural studies and magnetic resonance spectroscopy (2002) (25)
Thymus-derived B cell clones persist in the circulation after thymectomy in myasthenia gravis (2020) (25)
Congenital Myasthenic Syndromes (1993) (25)
Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behçet's disease (2011) (25)
Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis (2015) (25)
Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population (2014) (25)
Guidelines for pre-clinical assessment of the acetylcholine receptor-specific passive transfer myasthenia gravis model—Recommendations for methods and experimental designs (2015) (24)
Stimulation of human T cells by sparse antigens captured on immunomagnetic particles. (1992) (24)
Relative frequency of VGKC and ‘classical’ paraneoplastic antibodies in patients with limbic encephalitis (2008) (24)
Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica (2011) (24)
Immune‐mediated peripheral neuropathies and voltage‐gated sodiums channels (1999) (23)
Human nicotinic acetylcholine receptor α-subunit isoforms: origins and expression (1993) (23)
Motor Nerve Terminal Calcium Channels in Lambert‐Eaton Myasthenic Syndrome (1989) (23)
Pediatric Herpes Simplex Virus Encephalitis Complicated by N-Methyl-D-aspartate Receptor Antibody Encephalitis. (2015) (23)
Brain-relevant antibodies in first-episode psychosis: a matched case–control study (2017) (23)
Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study (2015) (22)
Preferential expression of AChR ε-subunit in thymomas from patients with myasthenia gravis (2008) (22)
Autoimmunity in paraneoplastic neurological disorders 1 This meeting was held at Somerville College, Oxford, April 6-7, 1997. 1 (1998) (22)
Guillain‐Barré syndrome associated with CASPR2 antibodies: two paediatric cases (2014) (22)
Epilepsy-related psychosis: A role for autoimmunity? (2014) (22)
Progress in autoimmune epileptic encephalitis. (2016) (22)
Autoimmune channelopathies (2005) (22)
Antibodies to Ion Channels in Paraneoplastic Disorders (1999) (22)
Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies (2010) (21)
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation (2020) (21)
Successful treatment of antiN-methyl-d-aspartate receptor limbic encephalitis in a 22-monthold child with plasmapheresis and pharmacological immunomodulation (2010) (21)
Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits. (1993) (21)
Purification of anti-acetylcholine receptor antibody from patients with myasthenia gravis. (1982) (21)
Immunoglobulin allotypes in caucasian and Chinese myasthenia gravis: differences from Japanese patients. (1988) (21)
Mutation of the acetylcholine receptor epsilon-subunit promoter in congenital myasthenic syndrome. (1999) (21)
Anti-NMDA receptor encephalitis with atypical brain changes on MRI. (2010) (21)
Human muscle acetylcholine receptor: cloning and expression in Escherichia coli of cDNA for the α-subunit (1989) (21)
Paroxysmal EEG pattern in a child with N‐methyl‐d‐aspartate receptor antibody encephalitis (2011) (20)
A candidate gene for autoimmune myasthenia gravis (2012) (20)
Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis. (1995) (20)
Lambert-Eaton syndrome antibodies: reaction with membranes from a small cell lung cancer xenograft (1988) (20)
Thymus, Thymoma, and Specific T Cells in Myasthenia Gravis a (1998) (20)
Faculty Opinions recommendation of Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction. (2016) (20)
Supranuclear gaze palsy in glycine receptor antibody‐positive progressive encephalomyelitis with rigidity and myoclonus (2012) (20)
Stiff-Person Syndrome: Autoimmunity and the Central Nervous System (2001) (20)
Bickerstaff’s encephalitis and Miller Fisher syndrome associated with voltage‐gated potassium channel and novel anti‐neuronal antibodies (2010) (20)
Amyotrophic lateral sclerosis and antibodies to voltage‐gated calcium channels—new doubts (1996) (19)
Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: A case report (2012) (19)
Cloning of cDNA encoding human rapsyn and mapping of the RAPSN gene locus to chromosome 11p11.2-p11.1. (1996) (19)
Anti-acetylcholine receptor idiotypes in myasthenia gravis analysed by rabbit anti-sera. (1985) (19)
Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy (2014) (19)
The coupling of the adenylate kinase and creatine kinase equilibria. Calculation of substrate and feedback signal levels in muscle (1970) (19)
Anti-N-methyl-D-aspartate-receptor encephalitis: cognitive profile in two children. (2012) (19)
α-Bungarotoxin binding to human muscle acetylcholine receptor: measurement of affinity, delineation of AChR subunit residues crucial to binding, and protection of AChR function by synthetic peptides (1998) (18)
Non-paraneoplastic limbic encephalitis characterized by mesio-temporal seizures and extratemporal lesions: A case report (2010) (18)
VGKC‐complex antibody mediated encephalitis presenting with psychiatric features and neuroleptic malignant syndrome – further expanding the phenotype (2012) (18)
Anti-NMDAR encephalitis misdiagnosed as Hashimoto's encephalopathy. (2014) (18)
Characterisation of a syndrome of autoimmune adult onset focal epilepsy and encephalitis (2014) (18)
Amyotrophic lateral sclerosis. An autoimmune disease? (1995) (18)
Muscle Nicotinic Acetylcholine Receptor mRNA Expression in Hyperplastic and Neoplastic Myasthenia Gravis Thymus a (1998) (18)
Autoantibodies, neurotoxins and the nervous system (1995) (18)
Myasthenia Gravis With Antibodies Against Muscle Specific Kinase: An Update on Clinical Features, Pathophysiology and Treatment (2020) (18)
Clinical characteristics, prognosis, and seropositivity to the anti-aquaporin-4 antibody in Korean patients with longitudinally extensive transverse myelitis (2010) (18)
Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension (2010) (18)
Ocular neuromyotonia in a 15-year-old girl after radiation therapy. (2008) (18)
EEG-confirmed epileptic activity in a cat with VGKC-complex/LGI1 antibody-associated limbic encephalitis. (2014) (18)
Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis (1992) (18)
A Prospective Study of the Incidence of Myasthenia Gravis in the East Midlands of England (2019) (18)
Progressive Encephalomyelitis with Rigidity and Myoclonus: A Syndrome with Diverse Clinical Features and Antibody Responses (2013) (18)
In vivo Mechanisms of Antibody-Mediated Neurological Disorders: Animal Models and Potential Implications (2020) (18)
Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia. (2012) (17)
Hemangioblastomatosis in a patient with von Hippel-Lindau disease (2007) (17)
Lambert‐Eaton Myasthenic Syndrome IgG: Early Morphologic Effects and Immunolocalization at the Motor Endplate a (1987) (17)
Acquired neuromyotonia in a patient with spinal epidural abscess (1998) (17)
Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination (2015) (17)
Autoimmune movement disorders. (2016) (17)
A sensitive radioimmunoprecipitation assay for assessing the clinical relevance of antibodies to IFN β (2003) (17)
Experimental Autoimmune Myasthenia Gravis (1994) (16)
ImmunoglobuliN in the Treatment of Encephalitis (IgNiTE): protocol for a multicentre randomised controlled trial (2016) (16)
Neue serologische Marker zur Differentialdiagnose der Autoimmun-Enzephalitis/New serological markers for the differential diagnosis of autoimmune limbic encephalitis (2011) (16)
The clinical profile of NMOSD in Australia and New Zealand (2020) (16)
Acetylcholine receptor antibody: clinical and experimental aspects. (1982) (16)
Focal status epilepticus and progressive dyskinesia: A novel phenotype for glycine receptor antibody-mediated neurological disease in children. (2017) (16)
ANTIBODIES AND RECEPTORS: From Neuromuscular Junction to Central Nervous System (2020) (16)
Cerebrospinal fluid hypocretin levels are normal in idiopathic REM sleep behaviour disorder (2010) (16)
Narcolepsy and H1N1 vaccination: a link? (2013) (16)
Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line (1994) (16)
ANTI-ACETYCHOLINE RECEPTOR ANTIBODIES IN PENICILLAMINE TREATED PATIENTS WITHOUT MYASTHENIA GRAVIS (1980) (16)
Differences in fine specificity of anti-acetylcholine receptor antibodies between subgroups of spontaneous myasthenia gravis of recent onset, and of penicillamine induced myasthenia. (1988) (16)
Acute Measles Encephalitis in Partially Vaccinated Adults (2013) (16)
Antibodies to AMPA receptors in Rasmussen's encephalitis. (2016) (16)
ENDPLATE DESTRUCTION DUE TO MATERNAL ANTIBODIES IN ARTHROGRYPOSIS MULTIPLEX CONGENITA (2009) (16)
Pitfalls in the detection of N-methyl-d-aspartate-receptor (NMDA-R) antibodies. (2017) (16)
EFNS Task Force Report: a questionnaire‐based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres (2000) (16)
Guillain‐Barré‐like syndrome associated with lung adenocarcinoma and CASPR2 antibodies (2013) (16)
Inflammatory and Autoimmune Disorders of the Nervous System in Children (2010) (16)
Immunotherapy responsive startle with antibodies to voltage gated potassium channels (2009) (16)
Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholine receptor-redirected T cells. (2013) (16)
Revised diagnostic criteria for neuromyelitis optica—incorporation of NMO-IgG status (2007) (16)
A role for autoantibodies in some cases of acquired non-paraneoplastic gut dysmotility. (2001) (16)
MuSK-antibody-positive myasthenia gravis in a South Asian population (2009) (15)
Anti-N-methyl-D-aspartate-receptor encephalitis in a four-year-old girl. (2010) (15)
Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO (2015) (14)
Measuring and evaluating the significance of autoantibodies in neurological disorders (2002) (14)
Detection of α-subunit isoforms in human muscle acetylcholine receptor by specific T cells from a myasthenia gravis patient (1993) (14)
4 Acetylcholine receptors and myasthenia gravis (1983) (14)
Anti-NMDA receptor encephalitis: a video case report. (2009) (14)
COMBINED PLASMA EXCHANGE AND IMMUNOSUPPRESSION IN MYASTHENIA GRAVIS (1979) (14)
Multimodal Biomarkers Quantify Recovery in Autoimmune Autonomic Ganglionopathy (2021) (13)
Autoantibody testing in encephalopathies (2012) (13)
[Plasmapheresis for myasthenia gravis]. (1978) (13)
Identification of phospholipase A2 and neurotoxic activities in the venom of the New Guinean small-eyed snake (Micropechis ikaheka). (1997) (13)
Myasthenia Gravis (2004) (13)
Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channels (2015) (13)
Antibodies to neuronal surface proteins in Tourette Syndrome: Lack of evidence in a European paediatric cohort (2019) (13)
Epitopes on human acetylcholine receptor α-subunit: binding of monoclonal antibodies to recombinant and synthetic peptides (1989) (13)
Introduction to autoimmune neurology. (2016) (13)
Factitious Disorders with Predominantly Psychological Signs and Symptoms: A Conundrum for Forensic Experts (1994) (13)
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply. (2014) (13)
Autoimmunity in neuropsychiatric disorders. (2016) (13)
Anti-acetylcholine receptor antibodies induced in mice by syngeneic receptor without adjuvants. (1986) (13)
Demyelinating disease and anti-N-methyl-D-aspartate receptor immunoglobulin G antibodies: a case report (2014) (13)
Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient (2017) (13)
Axonal dysfunction with voltage gated potassium channel complex antibodies (2014) (13)
Fetal acetylcholine receptor inactivation syndrome A myopathy due to maternal antibodies (2015) (13)
Immunocapture and Identification of Cell Membrane Protein Antigenic Targets of Serum Autoantibodies* (2009) (12)
Successful 'passive transfer' of paraneoplastic stiff person syndrome with antibodies to an intracellular antigen. (2010) (12)
New-onset focal epilepsy with palatal tremor and glutamic acid decarboxylase antibodies responding to intravenous immunoglobulin (2008) (12)
Anti‐MuSK myasthenia gravis presenting with Epstein–Barr virus‐associated mononucleosis and immune‐mediated diabetes mellitus (2007) (12)
Prevalence of N-Methyl-d-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study (2020) (12)
Autoantibodies in Neurological Diseases (2012) (12)
Wasp sting induced autoimmune neuromyotonia (2006) (12)
Antibody specificity in myasthenia gravis. (1988) (12)
Acquired neuromyotonia in thymoma‐associated myasthenia gravis: a clinical and serological study (2019) (12)
Reduced serum uric acid levels in neuromyelitis optica: serum uric acid levels are reduced during relapses in NMO (2012) (12)
Limbic encephalitis presenting as a post-partum psychiatric condition (2011) (12)
Febrile infection-related epilepsy syndrome is not caused by SCN1A mutations (2012) (12)
Doxycycline for the treatment of nodding syndrome (DONS); the study protocol of a phase II randomised controlled trial (2019) (12)
Idiotype restriction in myasthenia gravis antibodies (1981) (12)
Epilepsy and Autoimmunity in Pediatric Patients (2014) (12)
False-positive acetylcholine receptor antibody results in patients without myasthenia gravis (2019) (12)
Recurrent Optic Neuritis Associated With MOG Antibody Seropositivity (2017) (12)
Minimal manifestation status and prednisone withdrawal in the MGTX trial (2020) (11)
Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis (2007) (11)
Neuroimmune disorders in COVID-19 (2022) (11)
Limbic Encephalitis Associated With Elevated Antithyroid Antibodies (2014) (11)
Acetylcholine receptor antibodies in the elderly and in Down's syndrome (1985) (11)
T243 AUTOIMMUNITY AGAINST THE BETA2 ADRENERGIC RECEPTOR AND MUSCARINIC 2 RECEPTOR IN COMPLEX REGIONAL PAIN SYNDROME (2011) (11)
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis (2020) (11)
Immunology of the neuromuscular junction and presynaptic nerve terminal. (1999) (11)
Acquired neuromyotonia in children with CASPR2 and LGI1 antibodies (2019) (11)
Autoimmune channelopathies: new antibody-mediated disorders of the central nervous system (2009) (11)
Interferon Beta Treatment in Neuromyelitis Optica (2017) (11)
Hypoventilation in glycine-receptor antibody related progressive encephalomyelitis, rigidity and myoclonus (2014) (11)
Anti-acetylcholine receptor antibody: use of polyethylene glycol as an aid to precipitation of antibody-receptor complexes in determination of light chain and subclass. (1982) (11)
Antibody-mediated central nervous system diseases (2018) (11)
Autoimmunity to acetylcholine receptors in myasthenia gravis. (1991) (11)
A clinico‐radiological phenotype of voltage‐gated potassium channel complex antibody‐mediated disorder presenting with seizures and basal ganglia changes (2012) (11)
Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis (2020) (11)
Pediatric Autoimmune Epileptic Encephalopathies (2017) (11)
Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain (2011) (11)
Autoimmune channelopathies: John Newsom-Davis's work and legacy A summary of the Newsom-Davis Memorial Lecture 2008 (2008) (11)
Glutamate receptor delta2 serum antibodies in paediatric opsoclonus myoclonus ataxia syndrome (2018) (11)
Paediatric myasthenia gravis: Prognostic factors for drug free remission (2019) (11)
SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody (2019) (10)
Immune-mediated pediatric epilepsies. (2013) (10)
Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody (2018) (10)
HLA antigens in penicillamine induced myasthenia gravis. (1983) (10)
Autoimmune disorders of the neuromuscular junction. (2008) (10)
Congenital Myasthenic Syndromes: Studies of the AChR and Other Candidate Genes a (1998) (10)
Persistent facial myokymia: an autoimmune aetiology? (2000) (10)
Lack of effect of Miller Fisher sera/plasmas on transmitter release from PC12 cells (1997) (10)
A Single Nucleotide Deletion in the ɛ Subunit of the Acetylcholine Receptor (AChR) in Five Congenital Myasthenic Syndrome Patients with AChR Deficiency a (1998) (10)
Acquired neuromyotonia after bone marrow transplantation (2000) (10)
Do we need to measure specific antibodies in patients with limbic encephalitis? (2017) (10)
Autoimmune neurological disease after cardiac surgery (2004) (9)
Neuromyotonia in association with systemic sclerosis (1999) (9)
Autoantibodies and pain (2016) (9)
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica (2013) (9)
Structural Abnormalities of the AChR Caused by Mutations Underlying Congenital Myasthenic Syndromes (2003) (9)
Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs (2020) (9)
85 – Myasthenia Gravis and Myasthenic Syndromes (2007) (9)
Thymoma and Autoimmune Neurological Disorders (1997) (9)
Rapsyn facilitates recovery from desensitization in fetal and adult acetylcholine receptors expressed in a muscle cell line (2019) (9)
PRIMARY STRUCTURE OF THE HUMAN MUSCLE ACETYLCHOLINE-RECEPTOR - CDNA CLONING OF THE GAMMA-SUBUNIT AND EPSILON-SUBUNIT (1993) (9)
Paraneoplastic cerebellar syndrome and sensory ganglionopathy with papillary thyroid carcinoma (2014) (9)
Lack of association between acetylcholine receptor ϵ polymorphisms and early‐onset myasthenia gravis (2004) (9)
First reported cases of anti-NMDA receptor encephalitis in Vietnamese adolescents and adults (2017) (9)
Anti-N-Methyl-D-Aspartate Receptor Encephalitis In A Young Child With Histological Evidence On Brain Biopsy Of Coexistent Herpes Simplex Virus Type 1 Infection. (2016) (9)
The active intrathecal B-cell response in LGI1-antibody encephalitis (2015) (9)
Searching for Serum Antibodies to Neuronal Proteins in Patients With Myalgic Encephalopathy/Chronic Fatigue Syndrome. (2019) (9)
Multimodal electrophysiological analyses reveal that reduced synaptic excitatory neurotransmission underlies seizures in a model of NMDAR antibody-mediated encephalitis (2021) (9)
An Animal Model of Maternal Antibodymediated Arthrogryposis Multiplex Congenita (AMC) a (1998) (9)
Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients. (2003) (9)
Maternal Immunity in Autism Spectrum Disorders: Questions of Causality, Validity, and Specificity (2020) (9)
Electrophysiological effects of myasthenic serum factors studied in mouse muscle (1983) (9)
APPEARANCE OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODIES COINCIDENT WITH ONSET OF MYASTHENIC WEAKNESS IN PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS (1983) (9)
Acetylcholine receptor antibody in Thai generalized myasthenia gravis patients. (2006) (9)
Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause (2018) (9)
Determination of anti-acetylcholine receptor antibodies in myasthenic patients by use of time-resolved fluorescence. (2002) (9)
Autoantibodies in Japanese patients with ocular myasthenia gravis (2020) (8)
Autoimmune myasthenia gravis. (2013) (8)
Immunogenicity of human recombinant acetylcholine receptor alpha subunit: cytoplasmic epitopes dominate the antibody response in four mouse strains. (1994) (8)
Differences in processing of an autoantigen by DR4:Dw4.2 and DR4:Dw14.2 antigen‐presenting cells (1995) (8)
Antibodies to Components of the Voltage-Gated Potassium Channel - Associated Complex: LGI1 and CASPR2 as Antigenic Targets in Limbic Encephalitis, Morvan's and Neuromyotonia (2010) (8)
Autoimmunity against the b 2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome (2011) (8)
POI14 Multiple sclerosis: a potential association with anti-N-methyl-d-aspartate receptor encephalitis (2010) (8)
Reduction in Serum Aquaporin-4 Antibody Titers During Development of a Tumor-Like Brain Lesion in a Patient With Neuromyelitis Optica: A Serum Antibody–Consuming Effect? (2015) (8)
N-Methyl-D-Aspartate Receptor Autoantibodies in Psychiatric Illness (2016) (8)
Experimental autoimmune myasthenia gravis induced in mice without adjuvant: genetic susceptibility and adoptive transfer of weakness. (1989) (8)
Targeting the fetal acetylcholine receptor in rhabdomyosarcoma (2013) (8)
Studies on Anti-Acetylcholine Receptor Antibody Synthesis by Peripheral Blood Lymphocytes in Myasthenia Gravis (1979) (8)
Maternal-Autoantibody-Related (MAR) Autism: Identifying Neuronal Antigens and Approaching Prospects for Intervention (2020) (8)
Are spontaneous anti-idiotypic antibodies against anti-acetylcholine receptor antibodies present in myasthenia gravis? (1988) (8)
Seronegative Myasthenia Plasmas and Non‐IgG Fractions Transiently Inhibit nAChR Function a (1998) (8)
Novel functional epsilon-subunit polypeptide generated by a single nucleotide deletion in acetylcholine receptor deficiency congenital myasthenic syndrome. (1999) (8)
Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder (2021) (8)
Treatment-responsive, reversible, autoimmune encephalitis in a child. (2012) (8)
Long-term clinical course with voltage-gated potassium channel antibody in Morvan’s syndrome (2013) (7)
Systemic and cerebrospinal fluid immune and complement activation in Ugandan children and adolescents with long‐standing nodding syndrome: A case‐control study (2020) (7)
Systemic delivery of human GlyR IgG antibody induces GlyR internalization into motor neurons of brainstem and spinal cord with motor dysfunction in mice (2020) (7)
LEMS IgG Binds to Extracellular Determinants on N‐Type Voltage‐Gated Calcium Channels, but Does Not Reduce VGCC Expression (2003) (7)
Comparison of N-methyl-d-aspartate receptor antibody assays using live or fixed substrates (2021) (7)
Multiple Sclerosis and Myasthenia Gravis (1985) (7)
Disorders affecting the acetylcholine receptor: myasthenia gravis and congenital myasthenia. (1987) (7)
Tissue-specific antibodies in myasthenia gravis. (1979) (7)
Autoantibodies to glutamic acid decarboxylase in patients with epilepsy and their relationship with type 1 diabetes: a pilot study (2015) (7)
Characterization of specific T cells in myasthenia gravis. (1994) (7)
Paraneoplastic cerebellar degeneration and lambert‐eaton myasthenia in a patient with merkel cell carcinoma and voltage‐gated calcium channel antibodies (2017) (7)
SERUM ANTIBODIES IN EPILEPSY (2009) (7)
Myasthenia gravis with MuSK antibodies (2005) (7)
Human nicotinic acetylcholine receptor alpha-subunit isoforms: origins and expression. (1993) (7)
Production of Fab Fragments against the Human Acetylcholine Receptor from Myasthenia Gravis Thymus Lambda and Kappa Phage Libraries a (1998) (7)
Is “seronegative” MG explained by autoantibodies to MuSK? (2005) (7)
Antibodies to Acetylcholine Receptors in Myasthenia Gravis (1989) (7)
Autoantibody Testing in the Diagnosis and Management of Autoimmune Disorders of Neuromuscular Transmission and Related Diseases (2009) (7)
Voluntary partial retraction of: Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes (2009) (6)
Receptors, antibodies and disease. (1982) (6)
Antibody-mediated disorders of neuromuscular transmission. (2004) (6)
Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine receptor antibodies. (1992) (6)
cDNA and Genomic Clones Encoding the Human Muscle Acetylcholine Receptor (1993) (6)
Neuromyotonia in association with essential thrombocythemia (2000) (6)
Antibodies to neuronal alpha7 acetylcholine receptor in patients with Rasmussen's encephalitis (2004) (6)
Maternal CASPR2 antibodies and neurodevelopmental disorders in the offspring: epidemiological findings and an animal model (2017) (6)
Immunological aspects of acetycholine receptors (1983) (6)
NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro (2007) (6)
Antibody-mediated neurological disease (1991) (6)
Salbutamol-responsive fetal acetylcholine receptor inactivation syndrome (2016) (6)
Voltage-Gated Potassium Channels Autoantibodies in a Child with Rasmussen Encephalitis (2014) (6)
[Acute encephalitis anti-ionotropic glutamate receptor activated N-methyl-D-aspartate (NMDAR): analysis of eleven pediatric cases in Argentina (Benito Yelín Award)]. (2013) (6)
Glycine Receptor Antibodies in Progressive Encephalomyelitis with Rigidity and Myclonus, Hyperekplexia and Stiff Person Syndrome (2009) (6)
Absence of anti-acetylcholine receptor antibodies in Praomys (Mastomys) natalensis. (1981) (6)
Amnesia, cerebral atrophy, and autoimmunity (vol 361, pg 1266, 2003) (2004) (6)
Surviving stiff-person syndrome: a case report (2011) (5)
Inhibition of Maternal-to-Fetal Transfer of IgG Antibodies by FcRn Blockade in a Mouse Model of Arthrogryposis Multiplex Congenita (2021) (5)
Temporal lobe seizures, amnesia and autoantibodies - identifying a potentially reversible form of non-paraneoplastic limbic encephalitis. (2005) (5)
Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer. (2008) (5)
Acetylcholine Receptor Autoantibodies (1996) (5)
Neuronal autoantibodies shape symptomatology, cognitive function and brain structure in subjects at ultra-high risk for psychosis (2018) (5)
NIACIN DEFICIENCY (1952) (5)
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis (2021) (5)
Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand (2013) (5)
Neuroimmunology of myasthenia gravis (1988) (5)
Neuronal antibody prevalence in children with seizures under 3 years (2020) (5)
Splice-site mutations in the achr epsilon subunit gene associated with congenital myasthenic syndrome (2000) (5)
K+‐Stimulated Ca2+ Influx in Cell Lines Derived from Small Cell Lung Cancer and Neuronal Tumors (1989) (5)
PAW33 Aquaporin-4 M 23 isoform provides a more sensitive assay for aquaporin-4 antibodies (2010) (5)
Acetylcholine receptors and myasthenia gravis. (1983) (5)
Disorders of the Human Neuromuscular Junction (1997) (5)
Autoantibodies in neuromuscular transmission disorders (2008) (5)
An Update on Antibody-Mediated Diseases (2010) (5)
Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist centre (2021) (5)
Expression of Muscle Proteins in Thymomas of Patients with Myasthenia Gravis a (1998) (5)
In vitro neuronal network activity as a new functional diagnostic system to detect effects of Cerebrospinal fluid from autoimmune encephalitis patients (2019) (5)
Detection and Characterization of MuSK Antibodies in Seronegative (2004) (4)
Steroid-responsive recurrent limbic encephalitis associated with small cell lung cancer and neuropil antibodies. (2011) (4)
Prospective study of cancer survival in patients with HuD-antibody-associated paraneoplastic neurological disorders (2021) (4)
Action of antibodies directed against the acetylcholine receptor on channel function at mouse and rat motor end‐plates. (1988) (4)
Myelin oligodendrocyte glycoprotein CSF testing needs testing (2019) (4)
Antibodies against muscle-specific kinase in juvenile myasthenia gravis. (2003) (4)
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis (2022) (4)
Targeting the Interleukin 6 Receptor to Treat Neuromyelitis Optica. (2015) (4)
Effect of Human Myasthenic Immunoglobulin G on Mouse Acetylcholine Receptor (1980) (4)
Neuronal Antibodies in Children with or without Narcolepsy following H 1 N 1-AS 03 Vaccination Thebault (4)
Detection of NMDARs Antibodies in Encephalitis. (2017) (4)
IMMUNOTHERAPY-RESPONSIVE STATUS EPILEPTICUS WITH ANTI-GLYCINE RECEPTOR ANTIBODY (2011) (4)
Mechanisms in myasthenia gravis (2005) (4)
Stiff person syndrome in South Asia (2016) (4)
Muscle acetylcholine receptor conversion into chloride conductance at positive potentials by a single mutation (2019) (4)
Antigenic Specificity of Monoclonal Antibodies Against Torpedo and Human Acetylcholine Receptor, and Use of These Antibodies to Investigate Myasthenia Gravis (1986) (4)
A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies (2015) (4)
Serum neuronal cell-surface antibodies in first-episode psychosis-Authors' reply. (2017) (4)
Central Nervous System Neuronal Surface Antibodies (2013) (4)
VGKC-complex antibody encephalitis. (2014) (4)
Case report: Headache and neurological deficits with CSF lymphocytosis (HaNDL) associated with P/Q type voltage-gated calcium channel antibodies (CACNA1A) (2020) (4)
Disentangling etiologies of CNS infections in Singapore using multiple correspondence analysis and random forest (2020) (4)
Recessive inheritance and variable pentrance of slow channel myasthenic syndromes (2002) (3)
Specific Antibodies in the Diagnosis and Management of Autoimmune Disorders of Neuromuscular Transmission and Related Diseases (2003) (3)
Antibodies to Myelin Oligodendrocyte Glycoprotein (MOG) in Children and Adults with Demyelinating Disorders (NMO) (2013) (3)
D17S1175: dinucleotide repeat polymorphism 5' to CHRNE. (1994) (3)
Autoantibodies to the N-Methyl-D-Aspartate Receptor in Adolescents With Early Onset Psychosis and Healthy Controls (2020) (3)
Antibody-mediated encephalitis and psychosis. (2012) (3)
Potential mechanisms in MuSK-myasthenia gravis (2014) (3)
Mice immunised with recombinant subunit of the human acetylcholine receptor (AChR) develop anti-AChR antibodies but not experimental autoimmune myasthenia gravis (EAMG) (1989) (3)
Spinal cord MRI features in neuromyelitis optica (NMO): characteristics and relationship with severity and recovery in longitudinally extensive transverse myelitis (LETM) attacks (2013) (3)
An in Vitro Model for Disease‐specific Immunotherapy in Myasthenia Gravis Using Soluble MHC Class II Bound to AChR‐derived Peptide a (1993) (3)
Neuronal surface antibodies are common in children with narcolepsy and active movement disorders (2020) (3)
Pathogenic antibodies to AQP4: Neuromyelitis optica spectrum disorder (NMOSD). (2021) (3)
More movements in neuroimmunology. (2012) (3)
Devic's neuromyelitis optica: An analysis of 47 patients and prognostic implications of NMO IgG status (2008) (3)
Autoimmune neurological disorders-does the age matter? (2018) (3)
Fetal acetylcholine receptor function reduced by serum from asymptomatic mother with history of fetal arthrogryposis (1994) (3)
John Newsom-Davis: clinician-scientist and so much more (2011) (3)
Faculty Opinions recommendation of Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. (2008) (3)
Immunotherapy: responsive autoimmune encephalopathy associated with bullous pemphigoid (2009) (3)
Acetylcholine receptors. (1975) (3)
Antibodies to AChRs in seronegative myasthenia gravis (2006) (3)
Evidence for an Association between Human Acetylcholine Receptor and Rapsyn a (1998) (3)
Use of Antibody Testing in Nervous System Disorders (2010) (3)
Voltage-Gated Potassium Channel Antibodies in Slow-Progression Motor Neuron Disease (2016) (3)
N-Methyl-d-aspartate receptor (NMDAR) antibodies in post herpes simplex virus encephalitis (HSVE) neurological relapse (2013) (3)
Serum glutamic acid decarboxylase 65 antibody levels in people with schizophrenia and their families (2005) (3)
Diagnostic algorithm for relapsing demyelinating syndromes of the CNS in children (2017) (3)
Corrigendum to “Autoimmune channelopathies: John Newsom-Davis's work and legacy: A summary of the Newsom-Davis Memorial Lecture 2008” [J. Neuroimmunol. 201–202 (2008) 245–249] (2009) (3)
A pilot study on neurological manifestations and antibodies against antigens in children with hematological and other cancers. (2013) (3)
Comparison and standardization of measurement of anti-acetylcholine receptor antibody between laboratories. (1988) (3)
0842 Myelin-oligodendrocyte glycoprotein antibody as a cause of acute disseminated encephalomyelitis with a neuromyelitis optica-like phenotype in adults (2012) (3)
NMDA RECEPTOR ANTIBODIES IN FIRST EPISODE PSYCHOSIS: PREVALENCE AND CLINICAL PHENOTYPE (2014) (3)
Heterogeneity and immunotherapy of specific T-cells in myasthenia gravis. (1997) (3)
Immunotherapy responsive startle with antibodies to voltage gated potassium channels (2007) (2)
Paraneoplastic neurological syndromes (2010) (2)
Autoimmune psychosis - Authors' reply. (2020) (2)
Potassium channel antibody associated encephalitis: A potentially treatable non-paraneoplastic limbic encephalitis (2004) (2)
AUTOANTIBODIES IN EPILEPSY (2007) (2)
Single channel properties of human muscle nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes (1994) (2)
HL A‐A2‐Restricted T‐Cell Line Recognizing an Epitope of the Human Acetylcholine Receptor a (1993) (2)
Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation (2001) (2)
A case of Miller Fisher syndrome with anti GQ1b in Thailand. (2007) (2)
AChR from cell line TE671 cannot replace human muscle AChR in the conventional diagnostic immunoprecipitation RIA. (1994) (2)
NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT (2009) (2)
Autoimmune Encephalitis—Antibody Targets and Their Potential Pathogenicity in Immunotherapy-responsive Syndromes (2013) (2)
The clinical phenotype of non-paraneoplastic voltage gated potassium channel antibody (VGKC Ab) associated CNS disease (2004) (2)
Expression of Voltage‐Gated Calcium Channels in Tumor Cell Lines of Neuroectodermal or Other Origin (1988) (2)
Autoantibodies in different forms of myasthenia gravis and in the Lambert-Eaton syndrome. (2008) (2)
Antiganglioside antibodies in peripheral neuropathies. (1998) (2)
α-Neurotoxin binding to the human nicotinic acetylcholine receptor (1990) (2)
Thymomas, myasthenia gravis, associated autoimmune diseases and antibodies against antigens at neuromuscular junction (2006) (2)
Neuronal antibody prevalence in children with seizures < 3 years: a prospective national cohort. (2020) (2)
Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients (2008) (2)
1645 Vgkc is dead: long live lgi1- and caspr2-antibodies. intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies (2017) (2)
NMJ+C10 Inhibition of the tyrosine phosphatase Shp2 alleviates the pathogeniceff ects of MuSK antibodies in vitro (2017) (2)
Limbic Encephalitis: Under-Recognition of Voltage-Gated Potassium Channel Antibodies (2007) (2)
New support for autoimmune basis of myasthenia gravis (1975) (2)
Childhood autoimmune myasthenia (2010) (2)
Immunology of Myasthenia Gravis: Recent Developments (1981) (2)
Acute evidence of CNS inflammation in patients with mitochondrial diseases. (P4.053) (2015) (2)
Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective (2022) (2)
Autoantibodies to voltage-gated potassium channels in acquired neuromyotonia (1994) (2)
Demyelinating disease and anti-N-methyl-D-aspartate receptor immunoglobulin G antibodies: a case report (2014) (2)
Acute onset of focal seizures, psychiatric features and confusion: a case of autoimmune encephalitis? (2012) (2)
A prospective whole Scottish population study of genetic and immune causes of epilepsy and complex febrile seizures in children under three years of age: the Genetic and Autoimmune Childhood Epilepsy (GACE) Study (2018) (2)
Acute disseminated encephalomyelitis associated with positive voltage gated potassium channel complex antibody. (2013) (2)
Comparison of Structural Changes in Nodding Syndrome and Other Epilepsies Associated With Onchocerca volvulus (2022) (2)
Monoclonal antibodies to the human acetylcholine receptor (1985) (2)
Reflections on the VIth International Congress of Neuroimmunology held at the Edinburgh International Conference Centre, Edinburgh, September 3–7, 2001 (2002) (2)
Faculty Opinions recommendation of Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome. (2002) (2)
Autoimmune and paraneoplastic autonomic neuropathies (2013) (2)
Neuronal Staining Patterns in Sera from Patients with Lambert‐Eaton Myasthenic Syndrome a (1998) (2)
Genetic and immune findings in complex febrile seizures and the epidemiology of Dravet syndrome: A nationwide cohort study. (2017) (2)
Juvenile and Neonatal Myasthenia Gravis (2014) (2)
Experimental myasthenia gravis — a new autoimmune model (1976) (2)
Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen (2002) (2)
1700 Expanding the phenotypic spectrum of progressive encephalomyelitis with rigidity and myoclonus syndrome (PERMS) associated with glycine receptor antibody: clinical and laboratory study of 20 patients (2012) (2)
Anti-NMDAR encephalitis: An encephalitis lethargica like illness (2010) (2)
Assessment of aquaporin-4 (AQP4) antibody assays in European diagnostic centres (2014) (2)
Behaviour and MRS studies in offspring of pregnancy mice injected with serum from women with two of more children with neurodevelopmental disorders (2000) (2)
Immunoreactivity to foetal acetylcholine receptor disappears during the 33D week of human foetal development and reappears with denervation (1989) (2)
PATU3 Autoantibodies in “seronegative” myasthenia gravis (2010) (1)
Faculty Opinions recommendation of Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. (2013) (1)
PP08.4 – 2929: Relapsing central nervous system demyelination in children with myelin oligodendrocyte glycoprotein (MOG) antibodies (2015) (1)
Creutzfeld-Jakob disease--reply. (2013) (1)
NEURONAL ANTIBODIES IN PAEDIATRIC EPILEPSY : CLINICAL FEATURES AND LONG-TERM OUTCOMES (2015) (1)
Diagnostic algorithm for relapsing acquired demyelinating syndromes of the central nervous system in children (P1.345) (2017) (1)
Involvement of cation channels in autoimmune disease. (1994) (1)
Pyridostigmine-induced microcephaly. (2001) (1)
A 45-year history of acquired autoimmune neuromyotonia (2006) (1)
RE-THINKING THE ROLE OF THE HUMAN HIPPOCAMPUS IN RETROGRADE EPISODIC MEMORY (2013) (1)
Correction: Immunization against GAD Induces Antibody Binding to GAD-Independent Antigens and Brainstem GABAergic Neuronal Loss (2013) (1)
LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY (2009) (1)
O26 – 1915 Immunological studies in rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome (2013) (1)
End of the bed (end of the video) diagnosis (2012) (1)
Central nervous system antibody-mediated diseases with autonomic involvement – Focus on VGKC-complex (LGI1, CASPR2), NMDAR and GlyR antibodies (2015) (1)
Faculty Opinions recommendation of Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis. (2016) (1)
G.P.10.07 Arthrogryposis multiplex congenita caused by maternal antibodies against fetal acetylcholine receptor subunits (2007) (1)
Genetic and antibody-mediated channelopathies at the neuromuscular junction. (1999) (1)
Motor end-plate analysis to diagnose immune-mediated myasthenia gravis in seronegative patients (2022) (1)
Viral vectors for immunisation against potassium channel Kv1.2 (2005) (1)
Congenital myasthenic syndromes. (1993) (1)
Erratum to: Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension (2010) (1)
Acquired Neuromyotonia Precipitated by Thyroid Surgery and Associated with Antiacetylcholine Receptor Antibodies (2006) (1)
Autoantibodies to the Muscle Specific Kinase, MuSK in Myasthenia Gravis seronegative for Acetylcholine Receptor Antibodies (2002) (1)
In vitro characterisation and neurosteroid treatment of an N-Methyl-D-Aspartate receptor antibody-mediated seizure model (2020) (1)
IVth Congress of the International Society of Neuroimmunology Amsterdam, the Netherlands, 23–27 October 1994 (1995) (1)
Autoantibodies at the neuromuscular junction - link to the central nervous system. (2014) (1)
A note on the structure of immunized endplates (1977) (1)
Autoimmune Neurological Disease Michael P. Pender Pamela A. McCombe (1996) (1)
Novel RUNX 1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD 56 expression (2007) (1)
Monoclonal antibodies to the α-bungarotoxin-binding site on acetylcholine receptors from Torpedo mamorata (1985) (1)
Monoclonal anti-acetylcholine receptor antibodies as probes for human acetylcholine-receptor in myasthenia gravis. (1988) (1)
Analysing the AChR genes in hereditary myasthenics (1991) (1)
Acid sensing ion channel 1 contributes to axonal degeneration in autoimmune CNS inflammation and provides a novel target for neuroprotection in multiple sclerosis (2008) (1)
PP08.9 – 2594: Glycine receptor antibody mediated progressive encephalomyelitis with rigidity and myoclonus (PERM) presenting as an abnormal startle response in an adolescent girl (2015) (1)
Republished review: Autoantibody testing in encephalopathies (2012) (1)
Immunology of the motor nerve terminal (1994) (1)
Faculty Opinions recommendation of Altered active zones, vesicle pools, nerve terminal conductivity, and morphology during experimental MuSK myasthenia gravis. (2016) (1)
Faculty Opinions recommendation of The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. (2002) (1)
CLINICAL FEATURES AND FOLLOW-UP OF 13 PATIENTS WITH ANTIBODIES AGAINST NMDA RECEPTORS (2009) (1)
Is the AChR α373–380 sequence a T or B cell epitope in thymoma associated-myasthenia gravis? (1994) (1)
Clinical presentation and prognosis in MOG-antibody disease: a UK study (vol 140, pg 12, 2017) (2018) (1)
Detection of antibodies against the N-methyl-d-aspartate receptor in a sub-group of patients diagnosed with Tourette's syndrome (2014) (1)
Neuroinflammation: Ways in Which the Immune System Affects the Brain (2015) (1)
Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies (2013) (1)
Expression of messenger RNA encoding muscle acetylcholine receptor & subunit in thymoma (1996) (1)
Standing on the shoulders of giants: 100 years of neurology and epidemic infections (2020) (1)
New Antibodies to Neuronal and Muscle Antigens (2002) (1)
Transcriptional control of CHRNA1 gene in thymus by a promoter SNP associated with onset of autoimmune myasthenia gravis (2006) (1)
Immunotherapy-responsive faciobrachial dystonic seizures (FBDS) associated with LGI1-antibodies: A differential diagnosis in movement disorder practice (2012) (1)
A novel antigenic target in Morvan's syndrome (2008) (1)
P23 Fluorescent receptors to light up the neuromuscular junction (2011) (1)
The Importance of Keeping in Mind the Diagnosis of N-Methyl-D-Aspartate Receptor Encephalitis (2016) (1)
A novel sensitive assay for aqueporin-4 antibodies (NMO-IgG) (2007) (1)
Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis (2007) (1)
Effects of seronegative myasthenic plasma on the voltage gated sodium channel and the ACH activated cation channel of a whole-cell voltage clamped muscle cell line (1991) (1)
Pathogenicity of autoantibodies in stiff-person syndrome (2008) (1)
EAMG induced in rabbits by immunization against peptides representing human AChR alpha 138-199. (1993) (1)
Neuroprotective autoimmunity—a double-edged sword? (2000) (1)
OR.23. Transcriptional Control of CHRNA1 Gene in Thymus By a Promoter SNP Associated with Onset of Autoimmune Myasthenia Gravis (2006) (1)
A cysteine residue close to the C-terminus of the E subunit is essential for surface acetylcholine receptor (AChR) expression: Implications for AChR deficiency syndrome (2002) (1)
RETROGRADE AMNESIA FOLLOWING AUTOIMMUNE LIMBIC ENCEPHALITIS (2014) (1)
Disorders of neuromuscular transmission. (2011) (1)
Cell-and single molecule-based methods to detect anti-NMDA receptor autoantibodies in first episode psychosis patients from the OPTiMiSE project (2017) (1)
Plasma from patients with raised anti-GM1 antibodies passively transfer conduction block (1994) (1)
GLYCINE RECEPTOR ANTIBODY MEDIATED PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY AND MYOCLONUS (PERM) PRESENTING WITH RESPIRATORY COMPROMISE IN A 40-YEAR-OLD MALE (2012) (1)
Patients with cervical dystonia thought to be secondary non responders to botulinum toxin treatment should be given a trial of EMG guided injections (2002) (1)
John Newsom-Davis. 18 October 1932—24 August 2007 (2019) (1)
Mutations in dok-7 underlie a congenital myasthenic syndrome with a (sic)Limb girdle broken vertical bar pattern of muscle weakness. (2006) (1)
SERONEGATIVE MYASTHENIA GRAVIS-CLINICAL/SEROLOGICAL ASPECTS (2014) (1)
Therapy-resistant temporal lobe epilepsy in a cat - Laboratory findings, diagnostic imaging and histopathological examination showed more than one possible aetiology (2017) (1)
Organic neuropsychiatry: a treatable cause of suicidal behaviour (2013) (1)
Population-based perspective of anti-neuronal autoantibodies in patients with idiopathic late onset cerebellar ataxia (ILOCA) (2004) (0)
Running title: A passive transfer model of CASPR2 antibodies (2019) (0)
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease (2017) (0)
Glycine receptor antibodies: pathogenic mechanisms and clinical corrlates (2014) (0)
Pathogenic mechanisms of glycine receptor antibodies and their clinical spectrum (2013) (0)
Early years , clinical training , Queen Square and the Royal Free Hospital (2011) (0)
SHP2: A Potential Therapeutic Agent for MuSK-Myasthenia (2017) (0)
ANTIACETYLCHOLINE RECEPTOR ANTIBODIES IN MYASTHENIA-GRAVIS AND RELATION TO THYMIC PATHOLOGY (1986) (0)
Long-term outcomes of NMDAR-Ab encephalitis in U.K. cases (2017) (0)
Reader Response: Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis (2021) (0)
Antibodies to125I-glutamic aciddecarboxylase in patients withstiff man syndrome (2011) (0)
Reply (2011) (0)
EARLY AND CONTINUED TREATMENT OF N-METHYL D-ASPARTATE RECEPTOR-ANTIBODY ENCEPHALITIS OPTIMISES OUTCOME OF A PREDOMINANTLY NON-PARANEOPLASTIC DISEASE (2009) (0)
Faculty Opinions recommendation of Increasing MuSK activity delays denervation and improves motor function in ALS mice. (2016) (0)
Immunological evidence fortheco-existence of theLambert-Eaton myasthenic syndrome and myasthenia gravis intwopatients (1991) (0)
Plasma exchange andimmunosuppressive (1981) (0)
Neuromuscular junction autoantibodies in seronegative myasthenia gravis patients from Sudan (2013) (0)
Video Presentations (2011) (0)
Faculty Opinions recommendation of A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. (2016) (0)
Faculty Opinions recommendation of A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1. (2004) (0)
IgG subclass of antibodies to Yo in patients with paraneoplastic cerebellar degeneration (1998) (0)
IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica (2008) (0)
Interleukin 12 is critical in the development of experimental autoimmune myasthenia gravis (1998) (0)
Binding of acetylcholine receptor α-subunit peptides to HLA-A2 (1991) (0)
Neuromyotonia: Clinical, Electrophysiological and Immunological Findings of 4 Cases (2013) (0)
Molecular analysis of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis (EAMG) (1994) (0)
A clinical/immunological neuromyelitis optica association study (2014) (0)
Faculty Opinions recommendation of Autoimmunity to the sodium-level sensor in the brain causes essential hypernatremia. (2010) (0)
Voltage gated potassium channels (VGKC) antibodies and their clinical significance (2008) (0)
162 The association of two rare neurological diseases: a multicentre study of 16 patients with AChR antibody myasthenia gravis and AQP4 antibody neuromyelitis optica spectrum disorder (2012) (0)
FP59-FR-06 Clinical and serological study of myasthenia gravis in a South Asian population using both radioimmunoprecipitation and cell-based assays (2009) (0)
IgM antibodies and phosphorylation of acetylcholine receptors (AChR) in seronegative myasthenia gravis (SNMG) (1998) (0)
Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders (2010) (0)
P06.3 Juvenile myasthenia gravis associated with autoimmune channelopathy and mixed connective tissue disease (2011) (0)
CONGENITAL AND AUTOIMMUNE DISEASES OF THE NEUROMUSCULAR JUNCTION (1985) (0)
Screening for antibodies in narcolepsy type 1 and type 2 (2017) (0)
[36] Antibodies to ion channels (1999) (0)
Role of ion channel autoantibodies in NK-cell antibody-dependent anti-tumour immunity in patients with paraneoplastic Lambert-Eaton syndrome (2009) (0)
Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain (2013) (0)
Excitatory and inhibitory neurotransmitters with interleukins correlations in neurodegenerative encephalopathies (2013) (0)
Book Reviews (2003) (0)
Eurojunction ’99. The 5th European Conference on Myasthenia gravis and Other Disorders of the Neuromuscular Junction (2000) (0)
Microtubule-associated tau protein serum level in patients with different neurodegenerative diseases (2013) (0)
Faculty Opinions recommendation of Transmission and spreading of tauopathy in transgenic mouse brain. (2009) (0)
Human hypocretin receptor 2 antibodies are rare in idiopathic narcolepsy (2016) (0)
Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica (2011) (0)
T242 A SERUM-BASED BIOASSAY FOR THE DIAGNOSIS OF COMPLEX REGIONAL PAIN SYNDROME (2011) (0)
A mouse model for fetal abnormalities caused by maternal autoantibodies to neuronal or muscle antigens (1998) (0)
Antibodies specific for fetal AChR induce arthrogryposis multiplex congenita in developing mice: an animal model for transfer of pathogenic antibodies (1997) (0)
The clinical DELTA-P score accurately predicts small cell lung cancer in the Lambert-Eaton myasthenic syndrome (2010) (0)
Book ReviewsAutoimmune Neurological DiseaseMichael P. Pender, Pamela A. McCombe, Cambridge University Press (1995), £55.00 (377 pages) ISBN 0 521 46113 8 (1996) (0)
Sjogren myelopathy and neuromyelitis Optica (2008) (0)
P247 Anti-N-methyl-D-aspartate-receptor (NMDAR) encephalitis in a 4-year-old girl (2009) (0)
Passive Transfer of Human CASPR2 Antibodies into Mice Causes Behavioral and Neuropathological Changes (2018) (0)
PREGNANCY OUTCOME IN AQUAPORIN-4 POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: A MULTI-CENTER RETROSPECTIVE COHORT STUDY (2014) (0)
2PS2.1 Autoantibodies in disorders of the central nervous system (2011) (0)
Identification of the epiphysis system in women with catamenial and/or circadian-dependent epileptic seizures during the different phases of the menstrual cycle (2008) (0)
P68 Improving diagnostic sensitivity and specificity of musk cell-based assays for myasthenia gravis (2014) (0)
Passive transfer of glycine receptor-antibody IgG induces anxiety-like behaviour in mice (P2.200) (2015) (0)
Molecular analysis of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis (EAMG) (1994) (0)
Fetal acetylcholine receptor function reduced by serum from asymptomatic mother with history of fetal arthrogryposis (1994) (0)
Autoantibodies to the N-methyl-D-aspartate receptor and seizure susceptibility in mice (2014) (0)
Good response to Ofatumumab in a child with severe relapsing Neuromyelitis Optica (2012) (0)
Sensitivity and specificity for NMO IgG assays in Australia and New Zealand (2018) (0)
NMDAR antibodies; cognitive and behavioural abnormalities in mice injected with patient IgG (2010) (0)
Immunological Studies in Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, Autonomic Dysregulation, and Neural Tumor (ROHHADNET) Syndrome (2014) (0)
Maternal CASPR2 antibodies in neurodevelopmental disorders: findings in human cohorts and in a rodent maternal transfer model (2016) (0)
Using AChR antibody titres to predict treatment responses in myasthenia gravis (2021) (0)
John Newsom-Davis - CV and publications list from JOHN NEWSOM-DAVIS. 18 October 1932 — 24 August 2007 (2019) (0)
Myasthenia in Chinese females (correction) (1988) (0)
Role of antineuronal autoantibodies in population based samples of apparently idiopathic late onset cerebellar ataxia (ILOCA) (2003) (0)
PO205 A prospective clinical and immunological study of late onset myasthenia gravis (2017) (0)
Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies (2015) (0)
The role of anti-glutamic acid decarboxylase autoantibodies (GAD-Ab) in idiopathic late onset cerebellar ataxia (ILOCA) (2004) (0)
Pathological mechanisms in patients with antibodies to glycine receptors (2014) (0)
Faculty Opinions recommendation of Bone marrow transdifferentiation in brain after transplantation: a retrospective study. (2004) (0)
Neurophysiological features in MuSK antibody positive myasthenia gravis (2007) (0)
Expression of voltage-gated calcium channels in tumour cell lines of neuroectodermal or other origin (1987) (0)
Short communication Immune responses to Campylobacter and serum autoantibodies in patients with complex regional pain syndrome (2005) (0)
Selecting T cell lines in myasthenia gravis (MG) using recombinant human autoantigen (1991) (0)
Maternal-to-foetal Transfer of Caspr2 Antibodies Associated with Autistic Features in Adult Mouse Offspring: M132wip. (2015) (0)
Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG (2010) (0)
Mouse T and B cell recognition epitopes on the recombinant human muscle acetylcholine receptor α-subunit (1989) (0)
OP87 – 3001: Paediatric neurological syndromes associated with glycine receptor antibodies (2015) (0)
The inflammatory role of TNF-α in experimental auto-immune neuritis is mediated by its receptor 1 to induce activated macrophages with a pro-inflammatory phenotype ( M 1 ) (2012) (0)
Autoantibodies to N-methyl D-aspartate receptors in autoimmune encephalitis (2011) (0)
MORVAN'S SYNDROME: CLINICAL AND SEROLOGICAL FINDINGS IN 27 CASES (2011) (0)
Binding of acetylcholine receptor alpha subunit peptides to MHC class I molecules (1991) (0)
The Use of Gene Immunisation To Study the Role of Antibodies to Voltage Gated Potassium Channels in Neuroimmunological Disease (2006) (0)
Autoimmune limbic encephalitis and Morvan’s syndrome (2010) (0)
Inflammation and Fetal Death Neuromyelitis Optica IgG Causes Placental (2013) (0)
T Cell Reactivity to Acetylcholine Receptor in Myasthenia Gravis (1990) (0)
AUTOANTIBODIES CAUSING REVERSIBLE INFLAMMATORY BRAIN DISEASE. (2015) (0)
Effect of lectins on ACHR function in TE671 cells: A possible model for seronegative MG plasma (1991) (0)
Encephalitis and schizophrenia: a matter of words reply (2012) (0)
Testing the effects of SHP2 inhibition on in vitro and in vivo models of neuromuscular junction disorders (2019) (0)
15. Neuronal Autoantibodies and Blood-Brain Barrier Disruption in Subjects at Ultra-High Risk for Psychosis. (2017) (0)
PO221 Pathological mechanisms of glycine receptor antibodies (2017) (0)
Erratum: Glycine receptor antibodies in PERM and related syndromes: Characteristics, clinical features and outcomes (Brain (2014) 137 (2178-2192) DOI:10.1093/brain/awu142) (2014) (0)
Clinical and immunological correlates in myasthenia gravisassociated with musk antibodies [Abstract] (2008) (0)
Fine specificity of an AChR-reactive T cell line from a young myasthenic patient (1991) (0)
Chapter 7 – Arthrogryposis (2015) (0)
Sequential voltage-gated potassium channel and aquaporin-4 antibodies in a patient with seropositive myasthenia gravis, limbic encephalitis and neuromyelitis optica (2008) (0)
Acquired neuromyotonia (Isaac's syndrome): Evidence for an antibody-mediated mechanism (1991) (0)
Calcium conductance and choline sensitivity of slow channel syndrome acetylcholine receptor mutants (2004) (0)
CHAPTER 90 – NEUROMUSCULAR JUNCTION DISORDERS (2007) (0)
MOG-IGG IN NMO AND NMO-LIKE DISORDERS (2014) (0)
Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient (2017) (0)
Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica (2010) (0)
PATHOLOGICAL MECHANISMS OF GLYCINE RECEPTOR ANTIBODIES (2014) (0)
Myelin oligodendrocyte glycoprotein (MOG) antibodies in children without oligoclonal bands predict a non-MS course of acquired demyelination syndrome (ADS). (2014) (0)
Epitopes on human ACHR defined by monoclonal antibodies (1987) (0)
Correlation between polymorphisms in the AChR gamma and delta subunit promoters and clinical phenotype in AChR deficiency patients (2004) (0)
01 What is seronegative MG? analysis of the Northern Irish MG population (2011) (0)
Inflammatory and autoimmune disorders in neuropsychiatry (2020) (0)
THE ROLE OF ADAPTIVE IMMUNITY IN PARKINSONIAN SYNDROMES (2016) (0)
Patients with complex regional pain syndrome have activating serum-autoantibodies against alpha 1 adrenoceptors and muscarinergic receptors (2011) (0)
PATU1 Characteristic faciobrachial dystonic seizures as an immunotherapy-responsive prodrome to voltage-gated potassium channel antibody-associated limbic encephalitis (2010) (0)
Lambert-Eaton myasthenic syndrome IgG identifies calcium channel subtypes in neuronal cell lines (1994) (0)
Electrophysiological, neuro-hormonal and neuropsychological response to immunotherapy in a case of atypical Morvan syndrome with limbic seizures (2008) (0)
A PROSPECTIVE CLINICAL AND IMMUNOLOGICAL STUDY OF LATE ONSET MYASTHENIA GRAVIS (2016) (0)
Cell-surface neuronal antibodies in patients with Japanese encephalitis virus (2014) (0)
T-Cell epitopes in patients with myasthenia gravis defined by the use of recombinant polypeptides of the humanacetylcholine receptor (1989) (0)
The evolving clinical spectrum of neuromyelitis optica (2008) (0)
Immune-mediated slow-channel syndrome: A new form of myasthenia (1998) (0)
Slow Channel Syndrome Revisited: 40 Years Clinical Follow-Up and Genetic Characterization of Two Cases. (2022) (0)
Antibodies to clustered acetylcholine receptor and thymic changes in seronegative myasthenia gravis (2007) (0)
Clinical and Immunological Features with Glycine Receptor Antibodies (2012) (0)
ASIC1 expression contributes to demyelination and axonal injury in EAE and MS (2009) (0)
Autoantibody-associated autoimmune-encephalitis in Sri Lankan patients (2015) (0)
P83 – 1562 Epilepsy and autoimmunitiy in pediatric patients (2013) (0)
Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica (2013) (0)
Autoantibodies to neuronal proteins in patients with epilepsy (2012) (0)
M.P.1.04 The effect of dok-7 on acetylcholine receptor clustering in C2C12 cells (2008) (0)
Arthrogryposis multiplex congenita associated with congenital myasthenic syndrome due to mutations in the acetylcholine receptor delta subunit (2000) (0)
Molecular and biophysical identity of orexin/hypocretin neurons (2004) (0)
Faculty of 1000 evaluation for Diagnostic and clinical classification of autoimmune myasthenia gravis. (2016) (0)
Failure to identify change in the cervical dystonia muscle pattern is the main cause of reduced response to BTXA (2003) (0)
Antibody-mediated and genetic channelopathies at the neuromuscular junction (1997) (0)
Neuromuscular Junction Autoimmunity (1998) (0)
AUTOANTITIJELA KOD ENCEFALOPATIJA (2012) (0)
P265 Anti-NMDAR auto-immune encephalitis (2009) (0)
Cloning and expression of human S-laminin. (1996) (0)
094 Anti-NMDA receptor antibodies disrupt cortical network activity in vitro (2012) (0)
Thymoma epithelial cells can present AChR antigens to specific T cells (1994) (0)
POC15 An unexpected result in a patient with subacute meningoencephalitis and severe intracranial hypertension (2010) (0)
Cellular Neurophysiology C37‐C58, PC19‐PC32 (2004) (0)
An Update on Antibody-Mediated Diseases Prof (0)
Voltage Gated Potassium Channel (VGKC)-complex antibodies in children: what do they mean? (2014) (0)
Stiff person syndrome in South Asia (2016) (0)
Supplementary material from "JOHN NEWSOM-DAVIS. 18 October 1932 — 24 August 2007 " (2019) (0)
Case 34-2011: a man with memory loss and partial seizures. (2012) (0)
Fluorescent receptors light up the neuromuscular junction (2011) (0)
GP230 Fetal acetylcholine receptor inactivation due to maternal myasthenia gravis: an underrecognised, devastating but potentially preventable and treatable disorder (2019) (0)
SERUM AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE ARE ASSOCIATED WITH REDUCED CORTICAL GABA LEVELS IN PATIENTS WITH EPILEPSY (2009) (0)
Glycine receptor antibodies: Clinical spectrum and pathogenic mechanisms of the antibodies (2012) (0)
P45 Seronegative myasthenia gravis – clinical and serological features (2014) (0)
MHC class II: peptide complexes, soluble peptide and anti-Vβ antibodies induce different characteristics of unresponsiveness in a CD4+ T cell clone (1997) (0)
Clinical Predictors of Encephalitis in UK Adults – A Multi-Centre Prospective Observational Cohort Study (2021) (0)
N-methyl D-aspartate Receptors (NMDAR) Antibodies Associated With Distinct Clinico-Radiological White Matter Syndromes: Clinical Evidence For An Anti-NMDAR Leukoencephalopathy? (P5.187) (2014) (0)
Flow cytometry as a new method for the detection of surface antigens/surface-binding autoantibodies (2000) (0)
N-methyl-D-aspartate receptor (NMDA) antibody encephalitis mimicking an autistic regression (2019) (0)
AHuman Recombinant Autoantibody-Based Immunotoxin Specific for the Fetal Acetylcholine Receptor Inhibits Rhabdomyosarcoma Growth In Vitro and in aMurine (2014) (0)
1600 The utility of SOX antibodies for cancer prediction in patients with paraneoplastic neurological disorders (2012) (0)
Assessment of autoimmunity in the pathogenesis of epilepsies in young women with long-standing intractable drug-resistant epilepsy (2008) (0)
“Spreading” of B cell determinants in experimental myasthenia gravis induced by acetylcholine receptor peptides (1994) (0)
Novel mutation in the muscle acetylcholine receptor a-subunit underlies a fast channel congenital myasthenic syndrome (2002) (0)
Autoantibodies and relation to clinical features in Sudanese patients with acquired autoimmune myasthenia gravis: a case control study (2013) (0)
O10.3. EXPOSURE TO COMMON INFECTIOUS PATHOGENS IN SUBJECTS AT CLINICAL HIGH RISK FOR PSYCHOSIS: CLINICAL AND IMMUNOBIOLOGICAL ASSOCIATIONS (2019) (0)
Faculty Opinions recommendation of Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes. (2001) (0)
INVESTIGATION OF AUTO-ANTIBODIES IN PATIENTS DIAGNOSED WITH FOCAL EPILEPSY (2013) (0)
In vitro neuronal network activity as a new functional diagnostic system to detect effects of Cerebrospinal fluid from autoimmune encephalitis patients (2019) (0)
N-methyl-d-aspartate limbic encephalitis: Diagnosis should respect well-recognized criteria (2010) (0)
Predictive Value of Anti-Ro Antibody Positivity for Anti-AQP4 Autoantibody Test Results in Patients with Demyelinating Disease of Central Nervous System (2012) (0)
alpha-neurotoxin binding to the human nicotinic acetylcholine receptor. (1990) (0)
Faciobrachial Dystonic Attacks: Seizures or Movement Disorder? Reply (2011) (0)
Lems antibody causes reduction of α-conotoxin binding sites in a human neuroblastoma cell line (1989) (0)
Disorders of neurotransmission. (2001) (0)
Faculty Opinions recommendation of A nasal proteosome adjuvant activates microglia and prevents amyloid deposition. (2008) (0)
PP14.3 – 2698: Prolonged cortical hyperexcitability during burst-suppression associated with glycine receptor antibodies (2015) (0)
Faculty Opinions recommendation of Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice. (2002) (0)
Clinical relevance of VGKC-complex antibodies in children (P6.253) (2015) (0)
The fourth transmembrane domain of the muscle nicotinic acetylcholine receptor epsilon subunit is not required for channel function (2000) (0)
GLYCINE RECEPTOR ANTIBODY—A MARKER FOR NMO/ NON-MS DEMYELINATION? (2015) (0)
Prediction model for small-cell lung cancer in the Lambert-Eaton myasthenic syndrome (2010) (0)
Clinical Features of MuSK Antibody Positive Seronegative Myasthenia Gravis (2005) (0)
Introduction - Approaches to Understanding Immune-Mediated Neurological Disorders: Measuring and Evaluating Autoantibodies to Neuronal Antigens (2002) (0)
CROSSING INTO ORGANIC NEUROPSYCHIATRY (2009) (0)
Faculty Opinions recommendation of A specific amyloid-beta protein assembly in the brain impairs memory. (2006) (0)
Faculty Opinions recommendation of Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. (2004) (0)
Lymphatic vessels and high endothelial venules in adult human thymi; Their disposition and reactivation in myasthenia gravis (2008) (0)
Faculty Opinions recommendation of Modelling paraneoplastic CNS disease: T-cells specific for the onconeuronal antigen PNMA1 mediate autoimmune encephalomyelitis in the rat. (2004) (0)
Myelin Oligodendrocyte Glycoprotein (MOG) Auto-Antibodies In Children Predicts A Non-MS Course Of Acquired Demyelination Syndrome (ADS). (P2.241) (2014) (0)
Faculty of 1000 evaluation for Thymoma related myasthenia gravis in humans and potential animal models. (2016) (0)
Faculty Opinions recommendation of A population-based study of measles, mumps, and rubella vaccination and autism. (2002) (0)
AUTOANTIBODIES IN ALZHEIMER DISEASE; (2014) (0)
IN75-FR-01 Ion channels as targets of autoimmunity in disorders of NMJ and CNS (2009) (0)
Presentation of endogenous acetylcholine receptor (AChR) by human myoblasts to AChR-specific CD4+ T helper cell clones from myasthenia gravis (MG) patients (1998) (0)
Faculty Opinions recommendation of Autoantigen microarrays for multiplex characterization of autoantibody responses. (2002) (0)
Spectrum of MOG Autoantibody-Associated Inflammatory Diseases in Pediatric Patients (P5.275) (2015) (0)
A sting in the tale - A unique case of wasp induced autoimmune neuromyotonia (2005) (0)
Hu and VGCC Antibodies Related to the Prognosis of Small Cell Lung Cancer (2003) (0)
Clinical and immunological correlates in myasthenia gravis associated with musk antibodies (2008) (0)
Antibody to aquaporin-4: serum levels correlate with clinical disease activity (2008) (0)
Human PERM IgG induces motor dysfunction in mice (2014) (0)
Modelling autoimmune narcolepsy in humanised mice (2008) (0)
Myasthenia Gravis and other Antibody-Associated Neurological Diseases (2006) (0)
cells by controlling CD56 expression Novel RUNX1 isoforms determine the fate of acute myeloid leukemia (2013) (0)
Advances in the clinical science of the motor unit: from motor neuron to neuromuscular junction. (2014) (0)
31 – Autoimmune and Genetic Disorders of the Neuromuscular Junction and Motor Nerve Terminal (2007) (0)
Faculty of 1000 evaluation for Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. (2016) (0)
RASH DECISIONS–DERMATOLOGICAL MANIFESTATIONS PRECEDING A PROGRESSIVE NEUROLOGICAL SYNDROME (2013) (0)
Myasthenia gravis thymus: Complement attack on epithelial and myoid cells (2007) (0)
SHP2 INHIBITION BY NSC-87877 RECOVERS THE PATHOGENIC IN VITRO EFFECTS OF MUSK-MG ANTIBODY SUBCLASSES (2018) (0)
Lectins affect ACHR function in TE671 cells: A possible model for seronegative MG plasma (1991) (0)
Clinical and serological study of myasthenia gravis in WuHan, China (2006) (0)
2FC1.2 The expanding clinical phenotype of paediatric autoimmune encephalitis – comparison of CNS autoantibody positive and negative cases (2011) (0)
Prognostic factors in aquaporin-4 antibody-mediated disease: UK and Japanese cohorts (2011) (0)
OP13 – 2799: Landau-Kleffner syndrome (LKS), continuous spike and waves during slow-wave sleep syndrome (CSWSS), and Rolandic epilepsy (RE) – A genetic and immunological study (2015) (0)
Myasthenia gravis — latest developments (1977) (0)
Antibodies to acetylcholine receptors and MuSK in myasthenia gravis and related disorders (2004) (0)
MuSK autoantibody positive myasthenia gravis in a 14 year old boy: difficulties in diagnosis and response to treatment with plasmapheresis and immunosuppression (2006) (0)
Antibodies against hypocretin receptor 2 are rare in narcolepsy. (2016) (0)
Faculty Opinions recommendation of Identification of ubiquitin ligases required for skeletal muscle atrophy. (2002) (0)
Detection of anti-calcium channel antibodies in the Lambert-Eaton myasthenic syndrome (LEMS) (1994) (0)
Significance of Neuronal Autoantibodies in Comparison to Infectious Etiologies among Patients Presenting with Encephalitis in a Region with a High Prevalence of Infections (2022) (0)
CA3 SUBFIELD VOLUME PREDICTS ANTEROGRADE AUTOBI- OGRAPHICAL MEMORY LOSS IN ORGANIC AMNESIA (2019) (0)
Differential diagnosis and utility of AQP4-antibody assays in an insidious case of longitudinally extensive transverse myelitis (2009) (0)
Video Session with Oral Presentations (2010) (0)
An experimental mouse model of musk antibody positive myasthenia gravis (2008) (0)
IDENTIFICATION OF A FIRST AND MAJOR GENE FOR ACQUIRED EPILEPTIC APHASIA (LANDAU-KLEFFNER SYNDROME) AND RELATED CHILDHOOD FOCAL EPILEPSIES AND ENCEPHALOPATHIES WITH SPEECH AND LANGUAGE DYSFUNCTION (2013) (0)
A passive transfer animal model of CASPR2 antibodies (2018) (0)
Faculty Opinions recommendation of Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. (2003) (0)
Identification of neurotoxic activities and preliminary fractionation of the venom of the New Guinean small-eyed snake (Micropechis ikaheka) (1995) (0)
Neurophysiological techniques in patients who are secondarily non-responsive to Botulinum toxin (2007) (0)
POC19 Anti-Hu paraneoplastic sensory neuronopathy with underlying squamous cell carcinoma of the lung (2010) (0)
Plasma from anti-AChR Ab negative MG patients reduces Na+ influx into TE671 cells (1989) (0)
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis in a 12-year-old girl: Typical symptoms help to consider diagnosis of this new treatable disorder (2008) (0)
A PROSPECTIVE CLINICAL AND IMMUNOLOGICAL STUDY OF LATE ONSET MYASTHENIA GRAVIS (2015) (0)
Faculty Opinions recommendation of Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis. (2016) (0)
B cell populations in the myasthenia thymus that bind Rituximab (anti-CD20) (2014) (0)
IN71-FR-03 Dyslipidemia and diabetic neuropathy (2009) (0)
Startling new antibody in an old Irish jumper (2008) (0)
Corrigendum for Ann. N.Y. Acad. Sci. 2018. 1413: 143–153 (2018) (0)
Faculty Opinions recommendation of Neurodegeneration: a failure of neuroregeneration? (2001) (0)
Autoimmune encephalitis and Morvan’s syndrome (2020) (0)
Analysing the AChR genes in hereditary myasthenia (1994) (0)
THE PREVALENCE OF ANTIBODIES AGAINST NEURONAL CELL SURFACE TARGETS IN ACUTE FIRST EPISODE PSYCHOSIS (2015) (0)
Neuromuscular transmission disorders (2013) (0)
Troubles de la neurotransmission (2001) (0)
Voltage-gated potassium channel antibody associated limbic encephalitis is relatively common, potentially treatable, and usually nonaraneoplastic (2003) (0)
Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders (2013) (0)
Myasthenia gravis: Antigen presentation by thymoma epithelial cells (1994) (0)
Lambert-Eaton myasthenic syndrome and survival in patients with small cell lung carcinoma (2008) (0)
MOG Antibody Positive Optic Neuritis in Adults (2012) (0)
ANTI‐ACETYLCHOLINE RECEPTOR ANTIBODY HETEROGENEITY IN DIFFERENT FORMS OF MYASTHENIA GRAVIS (1981) (0)
O07 The John Newsom-Davis Lecture: The neuromuscular junction – a wide spectrum of disease mechanisms (2010) (0)
Stimulation of Specific T Cells by Human A ChR Adsorbed to Immunomagnetic Particles (1993) (0)
Contactin 2 and contactin-associated protein 2 antibodies in patients with multiple sclerosis and clinically isolated syndrome (2012) (0)
Antibodies to voltage-gated (VG) ion channels and glutamic acid decarboxylase (CAD) in childhood forms of epilepsies (1998) (0)
The impact of neuromyelitis optica spectrum disorder on pregnancy outcome (2014) (0)
Antibody to Myelin Oligodendrocyte Glycoprotein in Adults with Inflammatory Demyelinating Disease of The CNS (2016) (0)
Isolation and characterization of rare circulating autoantibody-producing cells from patients with muscle-specific kinase myasthenia gravis (2018) (0)
PO154 A comparison of nmdar-antibody detection methods (2017) (0)
Reply: Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: a lurking catastrophe? (2020) (0)
The Oxford Experience: Clinical Features And Outcomes of 25 NMDAR-Ab Positive Patients Including Those With Atypical Presentations (P5.189) (2014) (0)
Serum autoantibodies against intracellular antigens in multiple sclerosis (2002) (0)
THE ROLE OF ORBICULARIS OCULI SINGLE FIBRE ELECTROMYOGRAPHY IN THE DIAGNOSIS OF MYASTHENIA GRAVIS WITH PREDOMINANT OCULAR PRESENTATION (2009) (0)
1633 Linear- versus conformational-protein directed autoantibodies in neuropsychiatric systemic lupus erythematosis (2017) (0)
Role of acetylcholine receptor antibody complexes in experimental autoimmune myasthenia gravis (1991) (0)
P263 Two children with NMDAr +ve limbic encephalitis (2009) (0)
CLINICAL AND SEROLOGICAL FEATURES OF LATE-ONSET MYASTHENIA GRAVIS (2009) (0)
C3a complement split product: possible biomarker of disease activity in patients with neuromyelitis optica (2013) (0)
138 Differences in outcomes in neuromyelitis optica between a Japanese cohort and a predominantly Caucasian cohort from the UK (2012) (0)
Isolation and expression of cDNAS for the human muscle nicotinic acetylcholine receptor (1989) (0)
A prospective study of the incidence of sub-clinical Lambert-Eaton Myasthenic Syndrome (LEMS) in patients with small cell lung cancer (SCLC). (2004) (0)
John Newsom-Davis, 1932–2007 (2007) (0)
A study of the acquired neuromyotonia phenotype of peripheral nerve hyperexcitability (2002) (0)
Correction (2011) (0)
PATHOGENIC MECHANISMS UNDERLYING MYASTHENIA GRAVIS ASSOCIATED WITH MUSK ANTIBODIES (2009) (0)
Relapsing Anti-Glycine Receptor Antibody Mediated Encephalitis with Rigidity and Myoclonus (P01.235) (2012) (0)
Faciobrachial Dystonic Seizures Are Immunotherapy-Responsive and Treatment May Prevent Amnesia (2012) (0)
Perilesional brain oedema in calcifi c neurocysticercosis: a target to prevent seizure recurrence? (2008) (0)
Spectrum of MOG autoantibody-associated demyelinating diseases in pediatric patients (2014) (0)
PO147 Myelin oligodendrocyte glycoprotein-antibody disease in the uk (2017) (0)
Juvenile myasthenia gravis associated with autoimmune channelopathy and mixed connective tissue disease (2012) (0)
T69. PERFORMANCE OF PATIENTS WITH NMDAR-AB ENCEPHALITIS COMPARED TO PATIENTS WITH SCHIZOPHRENIA AND HEALTHY CONTROLS USING FUNCTIONAL MAGNETIC RESONANCE IMAGING (F-MRI) AND A WORKING MEMORY PARADIGM (2018) (0)
P24.4 Standardisation of the extensor digitorum brevis (EDB) test. Its role in the diagnosis of secondary non-responsiveness to botulinum toxin a (BTXA) (2006) (0)
AChR antibody titer and clinical response to thymectomy in MG (1984) (0)
Pathogenic effects of antibodies from miller fisher syndrome in vitro (1994) (0)
MOG Antibodies in Adult and Pediatric Demyelinating Diseases (2012) (0)
Auto-antibodies in adult herpes encephalitis (2012) (0)
Cell-Expressed Untagged Aquaporin-4 M23 Isoform Provides a More Sensitive Assay for Detection of Antibodies in Neuromyelitis Optica Spectrum Disorders (2010) (0)
抗人乙酰胆碱受体单抗的致病性和可变区序列分析 (1996) (0)
Endocrinopathies in paediatric-onset Aquaporin 4 (AQP4) antibody neuromyelitis optica spectrum disorder (2017) (0)
The argument for growth hormone day curve testing in acromegaly; significant discrepancy between mean growth hormone and random growth hormone levels (2019) (0)
EPILEPSY AND THE IMMUNE SYSTEM " ... IS THERE ANTIBODY THERE? ... '' (2012) (0)
Morvan’s syndrome presenting sub-acutely post thymectomy (2007) (0)
Weekly thyroxine administration: a safe method to administer thyroxine when compliance issues arise (2007) (0)
A single-centre audit of treatment outcomes in 185 acromegaly patients under regular follow-up (2018) (0)
PL.04.01 Autoimmune processes in encephalopathy: a promise for treatment of psychiatric disorders (2013) (0)
Cushing's syndrome or is it? a case report (2008) (0)
Faculty Opinions recommendation of Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. (2010) (0)
Neuromuscular Junction (NMJ): Inherited and Acquired Disorders (2009) (0)
Investigating the pathogenic effects of antibodies against the VGKC-complex and N-methyl-D-aspartate receptor in CNS disorders (2013) (0)
Myasthenia Gravis and Related Disorders (2020) (0)
II. Receptor synthesis (0)
371 EFFECT OF THE INJECTION OF CRPS IgG SERUM FRACTION IN MICE (2009) (0)
Ricardo Miledi. 15 September 1927—18 December 2017 (2021) (0)
IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica (2007) (0)
DDH320 2947..2957 (2004) (0)
NMDA Receptor Antibody Encephalitis: A Two-Stage Predominantly Non-Paraneoplastic Disorder in Males and Females (2010) (0)
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain (2014) (0)
ACHR-specific T cell responses to ‘native’ human ACHR (1991) (0)
Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts (2022) (0)
Seven cases of relapsing myelitis with no identified cause (2008) (0)
FP59-FR-03 Serological diagnosis of MG in Tianjin, China, with non-radioactive assays for AChR and MuSK antibodies (2009) (0)
Chapter 68 – Acetylcholine Receptor and Muscle-Specific Kinase Autoantibodies (2013) (0)
Antibodies to ion channels. (1999) (0)
Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing (2007) (0)
Use of Anti‐Nerve Antibodies (2008) (0)
LATE ADULT ONSET TEMPORAL LOBE EPILEPSY WITH ANTIBODIES TO VOLTAGE GATED POTASSIUM CHANNELS (2009) (0)

This paper list is powered by the following services:

Other Resources About Angela Vincent

en.wikipedia.org

What Schools Are Affiliated With Angela Vincent?

Angela Vincent is affiliated with the following schools:

Angela Vincent's Academic­Influence.com Rankings

Angela Vincent's Degrees

Why Is Angela Vincent Influential?

Angela Vincent's Published Works

Published Works

Other Resources About Angela Vincent

What Schools Are Affiliated With Angela Vincent?

Angela Vincent's AcademicInfluence.com Rankings